###begin article-title 0
HtrA2/Omi Terminates Cytomegalovirus Infection and Is Controlled by the Viral Mitochondrial Inhibitor of Apoptosis (vMIA)
###end article-title 0
###begin p 1
Performed the experiments: AM LR. Analyzed the data: AM EM. Wrote the paper: AM EM. Conceived the experiments: LM EM. Designed the experiments: LM.
###end p 1
###begin p 2
###xml 333 334 333 334 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">v</underline>
###xml 339 340 339 340 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</underline>
###xml 362 363 362 363 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">i</underline>
###xml 375 376 375 376 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">a</underline>
###xml 194 197 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
###xml 1354 1357 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
###xml 1440 1443 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
Viruses encode suppressors of cell death to block intrinsic and extrinsic host-initiated death pathways that reduce viral yield as well as control the termination of infection. Cytomegalovirus (CMV) infection terminates by a caspase-independent cell fragmentation process after an extended period of continuous virus production. The viral mitochondria-localized inhibitor of apoptosis (vMIA; a product of the UL37x1 gene) controls this fragmentation process. UL37x1 mutant virus-infected cells fragment three to four days earlier than cells infected with wt virus. Here, we demonstrate that infected cell death is dependent on serine proteases. We identify mitochondrial serine protease HtrA2/Omi as the initiator of this caspase-independent death pathway. Infected fibroblasts develop susceptibility to death as levels of mitochondria-resident HtrA2/Omi protease increase. Cell death is suppressed by the serine protease inhibitor TLCK as well as by the HtrA2-specific inhibitor UCF-101. Experimental overexpression of HtrA2/Omi, but not a catalytic site mutant of the enzyme, sensitizes infected cells to death that can be blocked by vMIA or protease inhibitors. Uninfected cells are completely resistant to HtrA2/Omi induced death. Thus, in addition to suppression of apoptosis and autophagy, vMIA naturally controls a novel serine protease-dependent CMV-infected cell-specific programmed cell death (cmvPCD) pathway that terminates the CMV replication cycle.
###end p 2
###begin title 3
Author Summary
###end title 3
###begin p 4
###xml 1200 1207 1200 1207 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">detente</italic>
###xml 226 247 <span type="species:ncbi:10359">Human cytomegalovirus</span>
Cellular suicide is an effective host defense mechanism to control viral infection. Host cells encode proteins that induce infected cell death while viruses encode proteins that prevent death and facilitate viral replication. Human cytomegalovirus encodes vMIA to suppress host-initiated death pathways. Cytomegalovirus infection is controlled by the evolutionarily ancient mitochondrial serine protease, HtrA2/Omi. HtrA2/Omi levels rise dramatically within mitochondria at late times during viral infection, eventually overcoming viral control of a cell death pathway that is dependent on this serine protease and independent of the well-studied apoptotic cell death pathway that conventionally depends upon a class of proteases called caspases. vMIA naturally counteracts HtrA2/Omi-dependent cell death and allows infected cells to survive and produce virus for several days. The natural inhibitory role of vMIA can be overwhelmed by overexpression of HtrA2/Omi in virus-infected cells, but uninfected cells are insensitive to HtrA2/Omi-induced death. The broad distribution of HtrA2/Omi within mammalian host species suggests this may represent an ancient antiviral response or a process of viral detente that establishes the timing of infection. Either way, the success of cytomegalovirus rests in the balance between cell death initiation and the viral cell death suppressor vMIA.
###end p 4
###begin title 5
Introduction
###end title 5
###begin p 6
###xml 314 317 314 317 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000063-Mocarski1">[1]</xref>
###xml 433 436 433 436 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000063-Mocarski1">[1]</xref>
###xml 624 627 624 627 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000063-Mocarski1">[1]</xref>
###xml 700 703 700 703 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000063-Goldmacher1">[2]</xref>
###xml 704 707 704 707 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000063-McCormick1">[4]</xref>
###xml 757 760 757 760 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000063-McCormick2">[5]</xref>
###xml 761 764 761 764 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000063-Yu1">[7]</xref>
###xml 878 881 878 881 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000063-McCormick2">[5]</xref>
###xml 882 885 882 885 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000063-Yu1">[7]</xref>
###xml 924 927 924 927 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000063-McCormick2">[5]</xref>
###xml 1084 1087 1084 1087 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">var</italic>
###xml 1146 1149 1146 1149 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000063-Reboredo1">[6]</xref>
###xml 1150 1153 1150 1153 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000063-Yu1">[7]</xref>
###xml 1164 1167 1164 1167 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">var</italic>
###xml 1268 1271 1268 1271 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000063-McCormick2">[5]</xref>
###xml 1368 1371 1368 1371 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000063-McCormick2">[5]</xref>
###xml 1497 1500 1497 1500 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000063-Mocarski1">[1]</xref>
###xml 1617 1620 1617 1620 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000063-Dunn1">[8]</xref>
###xml 1621 1624 1621 1624 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000063-Terhune1">[9]</xref>
###xml 176 197 <span type="species:ncbi:10359">Human cytomegalovirus</span>
###xml 199 202 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
###xml 514 517 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
###xml 1067 1070 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
###xml 1493 1496 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
###xml 1765 1768 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
Cell death is central to viral infection, as an evolutionarily-conserved means to eliminate intracellular pathogens and as a way that lytic viruses mediate release of progeny. Human cytomegalovirus (CMV), the major infectious cause of birth defects as well as an important cause of opportunistic disease worldwide [1], remains cell-associated during productive replication. Release of progeny virus depends upon the exocytic pathway [1] and continues until cells die via a poorly understood fragmentation process. CMV is well-armed to modulate cell-intrinsic as well as extrinsic innate and adaptive host clearance pathways [1]. The product of the UL37x1 gene, vMIA, a potent suppressor of apoptosis [2]-[4], also controls the timing of infected cell death [5]-[7]. Premature death in vMIA-mutant virus-infected cells reduces the period of progeny release by three to four days [5]-[7] without affecting cell-to-cell spread [5]. All vMIA-mutant viruses exhibit this premature death phenotype, but the involvement of caspases and the impact on viral yield varies with CMV strain. AD169varATCC strain (AD-BAC) depends upon vMIA to a greater extent [6],[7] than TownevarATCC (Towne-BAC), although vMIA prolongs the period of viral replication and release in both strains [5]. Importantly, vMIA from either strain retains the capacity to block caspase-dependent apoptosis [5]. The caspase-independent death pathway that is blocked by vMIA is not known. Other cell death suppressors are encoded by CMV [1], but, aside from vMIA, only UL38 has been implicated in control of infected fibroblast death to prolong replication [8],[9]. Studies to date reveal a complexity of infected cell death and a need for a more complete understanding of events that naturally terminate CMV infection.
###end p 6
###begin p 7
###xml 214 218 214 218 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000063-Jaattela1">[10]</xref>
###xml 219 223 219 223 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000063-Golstein1">[12]</xref>
###xml 503 506 503 506 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000063-McCormick2">[5]</xref>
###xml 586 590 586 590 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000063-Lockshin1">[11]</xref>
###xml 591 595 591 595 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000063-Chipuk1">[13]</xref>
###xml 852 855 852 855 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000063-McCormick2">[5]</xref>
###xml 856 859 856 859 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000063-Yu1">[7]</xref>
###xml 983 986 983 986 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000063-McCormick2">[5]</xref>
###xml 434 437 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
###xml 1064 1067 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
Major pathways associated with death (apoptosis, necrosis, and autophagy) are triggered by specific host cell and immune system initiators and exhibit characteristic molecular events and cell morphological changes [10]-[12]. Proteases in the caspase, calpain, lysosomal cathepsin, and proteasomal serine protease classes are central to the execution of various death pathways. The fact that the premature death induced by vMIA-mutant CMV is resistant to inhibitors of caspases, cathepsins, and calpains [5] suggests a novel programmed pathway distinct from characterized death pathways [11],[13]. For those viral strains that have been characterized, infected cell death initiates approximately 7 to 10 days after infection of fibroblasts. In contrast, the premature death that occurs in vMIA mutant virus infection initiates 3 to 4 days postinfection [5]-[7]. The 12-24 h timing of individual cell fragmentation, association with cytopathic effect (CPE), and nominal impact of vMIA [5] all suggest that the final stages of productive replication terminate with a CMV infected cell-specific programmed cell death (cmvPCD).
###end p 7
###begin p 8
###xml 112 116 112 116 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000063-Roulston1">[14]</xref>
###xml 117 121 117 121 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000063-Polster1">[16]</xref>
###xml 209 212 209 212 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000063-McCormick2">[5]</xref>
###xml 213 216 213 216 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000063-Yu1">[7]</xref>
###xml 357 358 357 358 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">L</sub>
###xml 358 361 358 361 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000063-Goldmacher1">[2]</xref>
###xml 461 462 461 462 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">c</italic>
###xml 590 593 590 593 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000063-Goldmacher1">[2]</xref>
###xml 594 597 594 597 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000063-McCormick2">[5]</xref>
###xml 598 602 598 602 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000063-McCormick3">[17]</xref>
###xml 730 734 730 734 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000063-Hayajneh1">[18]</xref>
###xml 735 739 735 739 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000063-Smith1">[19]</xref>
###xml 780 784 780 784 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000063-Arnoult1">[20]</xref>
###xml 785 789 785 789 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000063-Poncet1">[21]</xref>
###xml 826 830 826 830 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000063-McCormick4">[22]</xref>
###xml 925 929 925 929 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000063-Nechushtan1">[23]</xref>
###xml 930 934 930 934 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000063-Frank1">[24]</xref>
###xml 1009 1013 1009 1013 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000063-Pauleau1">[25]</xref>
###xml 1150 1154 1150 1154 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000063-Arnoult1">[20]</xref>
###xml 1155 1159 1155 1159 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000063-Poncet1">[21]</xref>
###xml 1344 1348 1344 1348 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000063-Nechushtan1">[23]</xref>
###xml 1349 1353 1349 1353 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000063-Frank1">[24]</xref>
###xml 1354 1358 1354 1358 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000063-Antignani1">[26]</xref>
###xml 1359 1363 1359 1363 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000063-Takekawa1">[27]</xref>
###xml 1405 1409 1405 1409 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000063-Lee1">[28]</xref>
###xml 1434 1438 1434 1438 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000063-Szabadkai1">[29]</xref>
###xml 1439 1443 1439 1443 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000063-Perfettini1">[30]</xref>
###xml 135 138 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
Many DNA viruses encode antiapoptotic functions that sustain replication in the face of cell-intrinsic defenses [14]-[16]. vMIA equips CMV to counteract intrinsic host clearance pathways leading to cell death [5]-[7]. As an outer mitochondrial membrane protein, vMIA sits in a central position analogous to antiapoptotic Bcl-2 family members Bcl-2 and Bcl-xL[2], and prevents the formation of a mitochondrial permeability transition pore, release of cytochrome c and proapoptotic factors into the cytoplasm, and activation of executioner caspases. Unlike antiapoptotic Bcl-2 family members [2],[5],[17], vMIA lacks Bcl-2 homology domains but depends on an antiapoptotic domain that mediates interaction with GADD45 family members [18],[19]. vMIA also recruits BAX to mitochondria [20],[21] and disrupts mitochondrial networks [22]. This disruption normally accompanies BAX oligomerization at the outer mitochondrial membrane [23],[24], although vMIA mutants that fail to bind BAX continue to disrupt networks [25]. The vMIA-dependent recruitment of BAX does not lead to the formation of a transition pore complex or release of proapoptotic mediators [20],[21]. The contribution of BAX oligomerization or mitochondrial network disruption to cell death suppression remains to be investigated. Although both of these events are signs of apoptosis [23],[24],[26],[27] neither mitochondrial network disruption [28] nor BAX oligomerization [29],[30] are sufficient to induce apoptosis. These alterations are also associated with vMIA-mediated suppression of cell death during viral infection where the pathway(s) of death are not fully understood.
###end p 8
###begin p 9
###xml 94 98 94 98 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000063-Jaattela1">[10]</xref>
###xml 100 104 100 104 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000063-vanGurp1">[31]</xref>
###xml 105 109 105 109 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000063-Kroemer1">[33]</xref>
###xml 122 123 122 123 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">c</italic>
###xml 558 562 558 562 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000063-Gray1">[34]</xref>
###xml 563 567 563 567 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000063-Kadomatsu1">[36]</xref>
###xml 732 733 732 733 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">c</italic>
###xml 964 968 964 968 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000063-Suzuki1">[37]</xref>
###xml 1073 1077 1073 1077 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000063-Martins1">[35]</xref>
###xml 1079 1083 1079 1083 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000063-Suzuki1">[37]</xref>
###xml 1084 1088 1084 1088 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000063-Hegde1">[40]</xref>
###xml 1151 1155 1151 1155 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000063-Ekert1">[38]</xref>
###xml 1156 1160 1156 1160 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000063-Vaux1">[39]</xref>
###xml 1293 1297 1293 1297 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000063-Lipinska1">[41]</xref>
###xml 1298 1302 1298 1302 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000063-Spiess1">[43]</xref>
Consequences of mitochondrial release of proapoptotic mediators have been extensively studied [10], [31]-[33]. Cytochrome c controls apoptosome formation and downstream executioner caspase activation. Endonuclease G and apoptosis-inducing factor (AIF) promote nuclear events. Mitochondrial release of Smac/DIABLO and HtrA2/Omi overcomes the activity of inhibitor of apoptosis proteins (IAPs). The HtrA2/Omi proenzyme is processed within the mitochondria, removing a mitochondrial targeting sequence (amino terminal 33 amino acids) and a transmembrane domain [34]-[36]. Mature, active HtrA2/Omi resides in the intermembrane space, and is released into the cytoplasm through the transition pore complex at the same time as cytochrome c. Release of the serine protease HtrA2/Omi from mitochondria can result in two downstream effects: (1) cleavage of IAPs and an ultimate increase in caspase-dependent death and (2) trigger IAP-independent, caspase-independent death [37]. This latter pathway is also induced by extramitochondrial overexpression of HtrA2/Omi in the cytoplasm [35], [37]-[40]. The role of this serine protease as an inducer of cell death [38],[39] in mammalians seems opposite the role of the founding member of this protein family as a pro-survival serine protease in eubacteria [41]-[43]. Here, we demonstrate the central role of HtrA2/Omi executing a serine protease-dependent pathway that is controlled by vMIA during infection.
###end p 9
###begin title 10
Results
###end title 10
###begin title 11
Premature cell death in the absence of vMIA
###end title 11
###begin p 12
###xml 83 87 83 87 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000063-Marchini1">[44]</xref>
###xml 161 167 161 167 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000063-g001">Fig. 1</xref>
###xml 182 189 182 189 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="ppat.1000063.s001">Fig. S1</xref>
###xml 327 334 327 334 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000063-g001">Fig. 1A</xref>
###xml 444 451 444 451 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000063-g001">Fig. 1A</xref>
###xml 453 460 453 460 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="ppat.1000063.s001">Fig. S1</xref>
###xml 512 519 512 519 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="ppat.1000063.s001">Fig. S1</xref>
###xml 602 609 602 609 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000063-g001">Fig. 1C</xref>
###xml 813 820 809 816 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000063-g001">Fig. 1C</xref>
###xml 888 895 884 891 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000063-g001">Fig. 1B</xref>
###xml 897 904 893 900 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="ppat.1000063.s001">Fig. S1</xref>
###xml 930 933 926 929 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000063-McCormick2">[5]</xref>
###xml 1119 1126 1115 1122 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="ppat.1000063.s001">Fig. S1</xref>
###xml 1292 1299 1288 1295 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000063-g001">Fig. 1C</xref>
###xml 1467 1470 1459 1462 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000063-McCormick2">[5]</xref>
We evaluated cmvPCD during wild type (wt) virus (Towne-BAC, a GFP-expressing virus [44]) infection by scoring morphological changes in cells during replication (Fig. 1, supplemental Fig. S1). Termination of infection was associated with the accumulation of GFP-positive cell debris that remained associated with the monolayer (Fig. 1A). Cell fragmentation and death was first observed at 120 h postinfection in a small percentage of GFP+ foci (Fig. 1A, Fig. S1). GFP+ dead cell debris was observed only in foci (Fig. S1). Almost all (>90%) foci showed evidence of fragmentation by 240 h postinfection (Fig. 1C). Thus, cmvPCD occurred very late in infection, after maturation and release of progeny virus had peaked. GFP+ debris was observed much earlier during infection with vMIA null mutant virus, DeltaUL37x1 (Fig. 1C), although the fragmentation process appeared similar to wt virus (Fig. 1B, Fig. S1). As previously reported [5], a majority (70%) of mutant virus foci contained debris by 120 h due to the single GFP+ cells that started to fragment between 72 and 96 h postinfection prior to the formation of foci (Fig. S1). There was a gradual increase in foci containing fragmented cells between 120 and 192 h postinfection such that, by 192 h, >90% of foci contained fragmented cells (Fig. 1C). This was consistent with our previous report showing both viruses spread with equivalent efficiency but that DeltaUL37x1 induced premature caspase-independent death [5].
###end p 12
###begin title 13
Pattern and timing of cmvPCD in Towne-BAC and DeltaUL37x1-infected cells.
###end title 13
###begin p 14
Images of infected cell foci (multiplicity of infection [MOI] of 0.01) showing cmvPCD in Towne-BAC (A) and DeltaUL37x1 (B) infected cells at 120 h postinfection (hpi). GFP expression by the viruses was used to identify foci of infected cells. Original magnification x400. (C). The mean percentages (+/-standard deviation) of GFP+ foci with fragmented cells based on counting 400 infected foci each day. Infection was with a MOI of 0.0001. The mean+/-sd is depicted in all figures, except where indicated.
###end p 14
###begin title 15
DeltaUL37x1-initiated death is a late phase event
###end title 15
###begin p 16
###xml 94 101 90 97 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000063-g001">Fig. 1C</xref>
###xml 103 110 99 106 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="ppat.1000063.s001">Fig. S1</xref>
###xml 112 115 108 111 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000063-McCormick2">[5]</xref>
###xml 377 383 369 375 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000063-g002">Fig. 2</xref>
###xml 462 471 454 463 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000063-g002">Fig. 2A&#8211;E</xref>
###xml 530 541 522 533 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000063-g002">Fig. 2A, 2D</xref>
###xml 646 649 634 637 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000063-McCormick2">[5]</xref>
###xml 707 718 695 706 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000063-g002">Fig. 2A, 2D</xref>
###xml 799 805 787 793 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000063-g001">Fig. 1</xref>
###xml 807 814 795 802 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="ppat.1000063.s001">Fig. S1</xref>
Intact GFP+ DeltaUL37x1-infected cells appeared to fragment before virus spread to form foci (Fig. 1C, Fig. S1) [5]. To determine whether intact DeltaUL37x1-infected cells released progeny virus before fragmenting, we evaluated the formation of immediate early nuclear antigen positive (IE+) foci by immunofluorescence. Infected cells became IE+ earlier than they became GFP+ (Fig. 2). IE+ foci surrounding single GFP+ cells were detected at 72 h postinfection (Fig. 2A-E), when a majority (>50%) of GFP+ cells were still intact (Fig. 2A, 2D). Whether intact or fragmented, >99% of DeltaUL37x1-infected cells produced foci by 120 h postinfection [5]. Thus, most virus spread occurs before cells fragmented (Fig. 2A, 2D), suggesting that, like wt, mutant virus is released before infected cells die (Fig. 1, Fig. S1).
###end p 16
###begin title 17
cmvPCD follows maturation and release in Towne-BAC and DeltaUL37x1-infected cells.
###end title 17
###begin p 18
Representative fluorescent images of immediate early positive (IE+) nuclei in foci surrounding an intact, live (A) or fragmented, dead GFP+ cell (B). (GFP = green, indirect fluorescence of IE antigen = red; original magnification x200). (C-E) Percentage of total GFP+ (C), live GFP+ (D), or dead (debris) (E) GFP+ cells forming IE1+ foci at 72 and 96 h postinfection with DeltaUL37x1 or Towne-BAC (MOI of 0.001). A total of 300 GFP+ cells per virus were evaluated at each time for the experiment depicted. (F) Percentage of IE+ cells (live) at 96 h postinfection with DeltaUL37x1 (MOI of 0.003), comparing untreated cultures to cultures treated with 300 microg/ml PFA or 20 microM BDCRB from 1 h postinfection. Data are from a representative experiment in which a total of >1000 infected cells/foci were evaluated for each condition.
###end p 18
###begin p 19
###xml 334 345 334 345 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000063-g002">Fig. 2B, 2F</xref>
###xml 478 482 478 482 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000063-Wahren1">[45]</xref>
###xml 483 487 483 487 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000063-Underwood1">[46]</xref>
###xml 747 754 743 750 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000063-g002">Fig. 2F</xref>
###xml 1062 1069 1058 1065 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000063-g002">Fig. 2F</xref>
###xml 246 249 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
To confirm that the death of mutant virus-infected cells was dependent on late phase events, the DNA synthesis inhibitor phosphonoformate (PFA) or the DNA encapsidation inhibitor 2-bromo-5,6-dichlorobenzimidazole (BDCRB) was added at the time of CMV infection and cell fate was scored by staining for IE+ cells at 96 h postinfection (Fig. 2B, 2F). PFA inhibits late gene expression, including GFP, while BDCRB blocks virion maturation but allows late gene expression to proceed [45],[46]. Untreated control or BCDRB-treated infected cultures appeared similar, whereas PFA-treated cultures contained single IE+ cells that remained GFP-. Only about 30% of GFP+ cells or debris in untreated DeltaUL37x1-infected cells were IE+ at 96 h postinfection (Fig. 2F). The remaining 70% were no longer IE+, suggesting that IE expression was lost as cells fragmented. BDCRB-treated cells exhibited a pattern similar to untreated cells, suggesting that fragmentation was triggered by events prior to DNA encapsidation. All infected cells in PFA-treated cultures remained IE+ (Fig. 2F) and did not fragment, suggesting that initiation of cell death was dependent on events that followed viral DNA synthesis. Thus, initiation of death was dependent on cellular changes associated with viral DNA replication and/or late phase gene expression.
###end p 19
###begin title 20
cmvPCD proceeds rapidly through fragmentation to death
###end title 20
###begin p 21
###xml 29 33 29 33 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000063-Lockshin1">[11]</xref>
###xml 100 106 96 102 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000063-g003">Fig. 3</xref>
###xml 399 402 391 394 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000063-Mocarski1">[1]</xref>
###xml 403 407 395 399 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000063-Penfold1">[47]</xref>
###xml 408 412 400 404 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000063-Sanchez1">[48]</xref>
###xml 443 454 435 446 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000063-g003">Fig. 3A, 3F</xref>
###xml 459 466 451 458 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="ppat.1000063.s002">Fig. S2</xref>
###xml 468 471 460 463 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000063-McCormick2">[5]</xref>
###xml 529 536 521 528 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000063-g003">Fig. 3F</xref>
###xml 538 545 530 537 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="ppat.1000063.s002">Fig. S2</xref>
###xml 570 577 562 569 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000063-g003">Fig. 3G</xref>
###xml 645 654 637 646 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000063-g003">Fig. 3H&#8211;J</xref>
###xml 677 686 669 678 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000063-g003">Fig. 3C&#8211;E</xref>
###xml 813 820 805 812 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000063-g003">Fig. 3E</xref>
###xml 844 851 836 843 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000063-g003">Fig. 3J</xref>
###xml 904 910 896 902 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000063-g002">Fig. 2</xref>
###xml 988 995 980 987 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="ppat.1000063.s003">Fig. S3</xref>
###xml 1176 1185 1168 1177 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000063-g003">Fig. 3B&#8211;D</xref>
###xml 1200 1207 1192 1199 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000063-g003">Fig. 3K</xref>
###xml 1212 1219 1204 1211 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="ppat.1000063.s001">Fig. S1</xref>
###xml 1376 1383 1364 1371 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="ppat.1000063.s001">Fig. S1</xref>
###xml 1388 1390 1376 1378 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="ppat.1000063.s004">S4</xref>
###xml 1426 1432 1414 1420 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000063-g001">Fig. 1</xref>
###xml 1454 1460 1442 1448 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000063-g002">Fig. 2</xref>
###xml 1487 1493 1475 1481 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000063-g003">Fig. 3</xref>
###xml 117 120 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
We evaluated cell morphology [11] associated with death in DeltaUL37x1 and wt virus-infected cells (Fig. 3). Late in CMV infection, inclusions form within enlarged cells coincident with replication and maturation processes that take place in the nucleus as well as in the cytoplasm. At 72 h postinfection, DeltaUL37x1 and wt virus-infected cells exhibited similar nuclear and cytoplasmic inclusions [1],[47],[48] as well as enlarged cell CPE (Fig. 3A, 3F and Fig. S2) [5]. Stain for total nuclear DNA revealed a diffuse pattern (Fig. 3F, Fig. S2) that became distorted (Fig. 3G) and progressed through shrinkage and collapse and loss of nuclei (Fig. 3H-J) as cells fragmented (Fig. 3C-E). A similar process accompanied fragmentation in mutant or wt infected cells. The fragmentation process produced cell debris (Fig. 3E) lacking signs of DNA (Fig. 3J). Loss of nuclei scored by DNA stain or IE antigen (Fig. 2) was similar. Cell debris remained GFP+ and unstained by ethidium homodimer (Fig. S3), suggesting a non-necrotic death. Fragmentation was not synchronous in infected cultures, such that only 10% of infected cells exhibited intermediate fragmentation patterns (e.g. Fig. 3B-D) at any time (Fig. 3K and Fig. S1). The same types of morphological changes that started at 72 h in DeltaUL37x1-infected cultures started at 120 h postinfection in Towne-BAC-infected cells (Fig. S1 and S4). The fragmentation of GFP+ cells (Fig. 1), loss of IE+ cells (Fig. 2) and loss of DNA+ nuclei (Fig. 3) were all characteristic of cmvPCD in wt and premature death in mutant virus-infected cells.
###end p 21
###begin title 22
cmvPCD proceeds through cell fragmentation and nuclear collapse in the absence of chromatin condensation.
###end title 22
###begin p 23
Representative images showing stages of infected cell fragmentation and death in DeltaUL37x1 infected cultures (collected at 72 h postinfection). Fluorescent micrographs of GFP+ virus-infected cells (A-E) and Hoechst-stained nuclei (F-J) associated with fragmentation. (A, F) Cytomegalic infected cell without signs of fragmentation, (B, G) initial stages of fragmentation with intact nucleus, (C, H) fragmented cell body with collapsed nuclear body, (D, I) fragmented cell body with residual nuclear body, and (E, J) fragmented cell debris without residual nuclear material. Original magnification x1000. (K) Counts of GFP+ intact infected cells (Intact Cell), Hoechst positive fragmented cell bodies (Fragmented Cell), and Hoechst negative fragmented cell debris (Debris) at 72 and 96 h postinfection with DeltaUL37x1 (MOI of 0.002). Data are from a representative experiment in which a total of 750 infected cells/foci were evaluated for each time.
###end p 23
###begin title 24
Serine proteases induce cmvPCD
###end title 24
###begin p 25
###xml 120 123 116 119 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000063-McCormick2">[5]</xref>
###xml 279 283 275 279 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000063-Bruno1">[49]</xref>
###xml 284 288 280 284 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000063-Sato1">[62]</xref>
###xml 441 445 437 441 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000063-Burck1">[63]</xref>
###xml 606 613 598 605 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000063-g004">Fig. 4A</xref>
###xml 679 686 671 678 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000063-g004">Fig. 4B</xref>
###xml 870 877 862 869 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000063-g004">Fig. 4C</xref>
###xml 1189 1202 1181 1194 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000063-g004">Fig. 4A and C</xref>
###xml 1321 1328 1313 1320 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000063-g004">Fig. 4D</xref>
Previous work showing that caspases, cathepsins, or calpains were not involved in DeltaUL37x1-initiated premature death [5], lead us to evaluate the contribution of cellular serine proteases to this process. We started by assessing the impact of a broad-spectrum inhibitor, TLCK [49]-[62], because this inhibitor does not affect the viral maturational serine protease at concentrations that are sufficient to block cellular serine proteases [63]. Addition of TLCK (11, 33, or 100 microM) to infected cultures at 30 h lead to a concentration-dependent reduction in cell fragmentation at 72 h postinfection (Fig. 4A). These concentrations of inhibitor did not reduce virus yields (Fig. 4B). Thus, TLCK inhibited premature cell death without any impact on virus replication. When TLCK was added at 30 h and fragmented cells were counted at 72, 96, and 120 h postinfection (Fig. 4C), cell death was reduced approximately twofold, suggesting that serine proteases play a central role in the timing of fragmentation. Despite experiment-to-experiment variability in the levels and rate of fragmentation death observed between 72 and 120 h postinfection, TLCK consistently inhibited this process (Fig. 4A and C) and increased the proportion of live, intact cells while absolute numbers of GFP+ cells or debris remained the same (Fig. 4D). This result implicated serine proteases early in the premature death induced by mutant virus.
###end p 25
###begin title 26
The serine protease inhibitor TLCK prevents DeltaUL37x1-induced premature cmvPCD.
###end title 26
###begin p 27
###xml 1229 1232 1185 1188 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">var</italic>
(A) Percentage of dead GFP+ infected cells at 72 h postinfection in untreated cultures (U) or cultures treated with 11, 33, or 100 microM TLCK from 30 h postinfection with DeltaUL37x1 (MOI of 0.001). A total of 300 cells/foci were evaluated at each condition. (B) Virus yield at 120 h postinfection from cell cultures left untreated (U) or treated with 11, 33, or 100 microM TLCK from 30 h postinfection with DeltaUL37x1 or Towne-BAC (MOI of 0.001). (C) Percentage of fragmented GFP+ cells at 72, 96, or 120 h postinfection with DeltaUL37x1 (MOI of 0.005) in control cultures or cultures treated with 33 microM TLCK from 30 h postinfection. A total of 1450 cells/foci were evaluated at each condition. (D) Absolute numbers of live or dead GFP+ cells at 96 h postinfection with DeltaUL37x1 (MOI of 0.001) in untreated cultures or cultures treated with 33 microM TLCK from 30 h postinfection. (E) Percentage of dead GFP+ cells at 96 h postinfection with DeltaUL37x1 (MOI of 0.005) in untreated cultures or cultures treated with 33 microM TLCK, 25 microM zVAD.fmk, or 0.05% DMSO, added from 30 h postinfection. A total of 300 cells/foci were evaluated at each condition. (F) Percentage of live cells at 48 h postinfection with AD169varATCC (MOI of 3) following treatment with anti-Fas antibody to induce apoptosis in control cultures or cultures treated with 6, 12, or 25 microM zVAD.fmk, added at 24 h postinfection.
###end p 27
###begin p 28
###xml 117 120 113 116 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000063-McCormick2">[5]</xref>
###xml 356 363 352 359 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000063-g004">Fig. 4E</xref>
###xml 408 411 404 407 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000063-McCormick2">[5]</xref>
###xml 412 415 408 411 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000063-Reboredo1">[6]</xref>
###xml 416 420 412 416 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000063-Skaletskaya1">[64]</xref>
###xml 472 475 468 471 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">var</italic>
###xml 496 503 492 499 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000063-g004">Fig. 4F</xref>
###xml 456 459 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
Previously, we reported that the pan-caspase inhibitor zVAD.fmk had no effect on DeltaUL37x1-induced premature death [5]. To determine whether caspases influenced death levels when serine proteases were inhibited, we applied zVAD.fmk alone as well as in combination with TLCK. The caspase inhibitor did not influence the serine protease-dependent process (Fig. 4E). In contrast, zVAD.fmk showed the expected [5],[6],[64] inhibition of apoptosis induced in CMV strain AD169varATCC infected cells (Fig. 4F). Thus, these data imply that cmvPCD is controlled by serine proteases that work independent of caspases.
###end p 28
###begin title 29
The serine protease HtrA2/Omi initiates cmvPCD
###end title 29
###begin p 30
###xml 264 271 260 267 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000063-g005">Fig. 5A</xref>
###xml 347 354 343 350 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000063-g004">Fig. 4D</xref>
###xml 484 491 480 487 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000063-g002">Figs. 2</xref>
###xml 496 497 492 493 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000063-g003">3</xref>
###xml 503 506 499 502 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000063-McCormick2">[5]</xref>
###xml 746 753 742 749 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000063-g005">Fig. 5B</xref>
###xml 977 984 973 980 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000063-g005">Fig. 5B</xref>
###xml 541 544 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
To determine the timing of serine protease activity in controlling premature death, TLCK was added to DeltaUL37x1-infected cells at 30, 54, or 78 h. Addition of TLCK at each of these times was found to dramatically reduce the level of death at 96 h postinfection (Fig. 5A). These results suggest serine proteases act within 24 h of fragmentation (Fig. 4D) and demonstrated the importance of these proteases late in infection. Taken together with data on timing of the death stimulus (Figs. 2 and 3, and [5]), serine proteases active late in CMV infection may either trigger or play an intermediary role in the cell death pathway. To determine the timing of serine protease activity in wt virus-induced cmvPCD, TLCK was added at 30, 54, and 78 h (Fig. 5B). Addition of TLCK at each of these times effectively reduced cell fragmentation at 144 h postinfection, suggesting that proteases active after the 78 h time period played a critical role during wt virus infection as well (Fig. 5B). These data demonstrate a common serine protease cell death pathway terminates mutant or wt virus infection, and demonstrate that the premature death in mutant virus infected cells follows a similar pathway as cmvPCD. Differences in timing show the importance of vMIA control in the timing of cmvPCD.
###end p 30
###begin title 31
Inhibitors of serine protease HtrA2/Omi suppress cmvPCD.
###end title 31
###begin p 32
(A) Percentage of dead GFP+ cells at 96 h postinfection with DeltaUL37x1 (MOI of 0.01) in cultures treated with 100 microM TLCK from 30, 54, or 78 h postinfection relative to untreated cultures (U). 3000 cells/foci were evaluated at each condition. (B) Percentage dead GFP+ cells at 144 h postinfection with Towne-BAC (MOI of 0.03). 9000 cells/foci were evaluated at each condition. (C) Percentage of dead GFP+ cells at 96 h postinfection with DeltaUL37x1 in cultures treated with 10 microM UCF-101 from 30, 54, or 78 h postinfection relative to untreated cultures (U). 3000 cells/foci were evaluated at each condition. (D) Percentage of dead GFP+ cells at 144 h postinfection with Towne-BAC (MOI of 0.03). A total of 9000 cells/foci were evaluated at each condition. Data in A-D is depicted relative to untreated controls, which were assigned a value of 100%. (E) Yields of virus at 168 h postinfection (MOI of 0.01) with DeltaUL37x1 or Towne-BAC in untreated cultures or cultures treated with UCF-101 from 30 or 54 h postinfection.
###end p 32
###begin p 33
###xml 122 126 122 126 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000063-Hegde1">[40]</xref>
###xml 128 132 128 132 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000063-Srinivasula1">[65]</xref>
###xml 133 137 133 137 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000063-Seong1">[67]</xref>
###xml 180 184 180 184 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000063-Cilenti1">[68]</xref>
###xml 243 252 239 248 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000063-g005">Fig. 5C&#8211;E</xref>
###xml 366 370 358 362 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000063-Klupsch1">[69]</xref>
###xml 513 522 501 510 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000063-g005">Fig. 5C&#8211;D</xref>
###xml 657 664 641 648 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000063-g005">Fig. 5C</xref>
###xml 779 786 763 770 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000063-g005">Fig. 5D</xref>
###xml 836 843 820 827 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000063-g005">Fig. 5E</xref>
###xml 1149 1156 1133 1140 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000063-g005">Fig. 5A</xref>
One mitochondrial serine protease, HtrA2/Omi, has been implicated in cell death pathways and exhibits sensitivity to TLCK [40], [65]-[67]. The specific HtrA2/Omi inhibitor UCF-101 [68] was added to DeltaUL37x1- or Towne-BAC-infected cultures (Fig. 5C-E) at a concentration (10 microM) anticipated to minimize a previously recognized impact on other cellular targets [69]. UCF-101 reduced death when added to DeltaUL37x1 or Towne-BAC-infected cultures at 30 or 54 h, implicating HtrA2/Omi as a mediator of cmvPCD (Fig. 5C-D). Although UCF-101 added at 54 h reduced death of DeltaUL37x1-infected cells at 96 h postinfection, addition at 78 h was ineffective (Fig. 5C). Towne-BAC-associated death at 144 h was reduced by UCF-101 added as late as 102 h, but not when added at 126 h (Fig. 5D). UCF-101 treatment did not reduce viral yields (Fig. 5E). Most importantly, these data suggest that events over the 24 to 48 h preceding fragmentation of cells are influenced by HtrA2/Omi, regardless of whether considering the premature cmvPCD in mutant virus infected cells or cmvPCD in wt infection. The differences between UCF-101 and TLCK addition at 78 h (Fig. 5A) may be due to the effectiveness of these inhibitors on HtrA2/Omi or to additional serine proteases that contribute to cmvPCD. Overall, these data demonstrate that UCF-101 specifically reduces infected cell death and implicate the serine protease HtrA2/Omi in the pathway. Further, these data implicate HtrA2/Omi as a target of vMIA modulation.
###end p 33
###begin title 34
HtrA2/Omi levels increase late in infection
###end title 34
###begin p 35
###xml 247 253 247 253 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000063-g006">Fig. 6</xref>
###xml 419 428 419 428 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000063-g006">Fig. 6A&#8211;B</xref>
###xml 521 528 521 528 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000063-g006">Fig. 6B</xref>
###xml 530 537 530 537 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="ppat.1000063.s005">Fig. S5</xref>
###xml 805 814 805 814 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000063-g006">Fig. 6C&#8211;H</xref>
###xml 819 826 819 826 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="ppat.1000063.s006">Fig. S6</xref>
###xml 917 928 917 928 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000063-g006">Fig. 6C, 6F</xref>
###xml 933 940 933 940 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="ppat.1000063.s006">Fig. S6</xref>
To determine the impact of mutant or wt virus infection on HtrA2/Omi expression levels and subcellular localization as well as to investigate any impact of vMIA on HtrA2 expression, immunoblot analysis was carried out on Towne-BAC infected cells (Fig. 6). Levels of mature 36 kDa HtrA2/Omi levels were similar to uninfected cells at 24 h, but increased by 48 h and continued to accumulate over the course of infection (Fig. 6A-B). Comparisons of mutant and wt infected cells showed similar accumulation of HtrA2 by 48 h (Fig. 6B, Fig. S5). Premature cmvPCD initiated in mutant virus-infected cells prevented comparisons by immunoblot later in infection; however, immunofluorescence analyses at 96 h postinfection confirmed the dramatically increased HtrA2/Omi levels in mutant or wt virus-infected cells (Fig. 6C-H and Fig. S6). HtrA2/Omi colocalized with the mitochondrial membrane potential marker MitoTracker Red (Fig. 6C, 6F and Fig. S6) at late times of infection with either virus. These data indicate that HtrA2/Omi levels increase within mitochondria before the initiation of cmvPCD. vMIA does not alter expression pattern or mitochondrial localization of this protease but nevertheless prevents death.
###end p 35
###begin title 36
###xml 41 44 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
HtrA2/Omi expression increases following CMV infection.
###end title 36
###begin p 37
###xml 566 567 559 560 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">c</italic>
(A-B) Immunoblot analyses of HtrA2/Omi in lysates of mock-infected HF (M) or HF infected (MOI of 3) with Towne-BAC or DeltaUL37x1 for 24, 48, 72, 96, or 120 h and control cell lysates from HeLa cells transfected with HtrA2/Omi expression plasmid (+) or control plasmid (-). The expected migration of the 49 kDa immature, pro-HtrA2/Omi and 36 kDA mature, HtrA2/Omi was calculated based on migration of molecular weight markers (not shown). Immunoblot detection of HtrA2, beta-actin and IE1 are shown. (C-N) Immunofluorescent images of HtrA2/Omi (C, F) and cytochrome c (I, L) (red), and GFP fluorescence (green) (D, G, J, M) and merged images (E, H, K, N) at 72 h (C-H) or 96 h (I-N) postinfection (MOI of 0.001) with DeltaUL37x1 (C-E, I-K) or Towne-BAC (F-H, L-N). Original magnification x1000.
###end p 37
###begin p 38
###xml 60 64 60 64 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000063-McCormick4">[22]</xref>
###xml 152 163 152 163 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000063-g006">Fig. 6F, 6L</xref>
###xml 169 176 169 176 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="ppat.1000063.s006">Fig. S6</xref>
###xml 240 251 240 251 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000063-g006">Fig. 6C, 6I</xref>
###xml 256 263 256 263 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="ppat.1000063.s006">Fig. S6</xref>
###xml 304 305 304 305 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">c</italic>
###xml 498 505 498 505 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="ppat.1000063.s006">Fig. S6</xref>
###xml 1173 1177 1165 1169 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000063-Sanchez1">[48]</xref>
###xml 1178 1182 1170 1174 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000063-Das1">[70]</xref>
###xml 1223 1230 1215 1222 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="ppat.1000063.s002">Fig. S2</xref>
###xml 1232 1239 1224 1231 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="ppat.1000063.s006">Fig. S6</xref>
###xml 19 22 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
Mitochondria in wt CMV infected cells followed the expected [22] reticular to punctate transition associated with disruption of mitochondrial networks (Fig. 6F, 6L, and Fig. S6) and mutant virus-infected cells retained a reticular pattern (Fig. 6C, 6I and Fig. S6) when stained for HtrA2/Omi, cytochrome c, mitochondrial HSP (mtHSP70), or MitoTracker Red. MitoTracker Red staining indicated that mitochondria retained a similar membrane potential despite this difference in morphology due to vMIA (Fig. S6). When the kinetics of the reticular to punctate transition was evaluated in Towne-BAC-infected cells, almost all (>/=90%) of cells contained reticular mitochondria at 48 h, but transitioned to punctate by 96 h. In contrast, DeltaUL37x1-infected cells retained a reticular morphology (>/=80%) throughout infection. These data suggest that a vMIA-dependent process disrupts reticular mitochondria beginning at 48 h postinfection and this change in mitochondrial organization may contribute to cell survival. Despite this striking difference in mitochondria, the organelles of the secretory apparatus that form the viral assembly compartment at late times of infection [48],[70] were similar in either virus infection (Fig. S2, Fig. S6). Thus, disruption of mitochondrial networks by wt virus may contribute to control of HtrA2/Omi-dependent death and the failure of mutant virus to induce these changes may lead to premature HtrA2/Omi-dependent death.
###end p 38
###begin p 39
###xml 64 65 64 65 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">c</italic>
###xml 168 169 168 169 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">c</italic>
###xml 180 186 180 186 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000063-g006">Fig. 6</xref>
###xml 191 198 191 198 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="ppat.1000063.s006">Fig. S6</xref>
###xml 278 285 278 285 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="ppat.1000063.s007">Fig. S7</xref>
###xml 334 335 334 335 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">c</italic>
We sought to determine whether mitochondria released cytochrome c prior to premature cmvPCD. Cells that had not yet started to fragment all showed reticular cytochrome c staining (Fig. 6 and Fig. S6) whereas diffuse staining was detected only as cells became highly fragmented (Fig. S7). These data suggest that release of cytochrome c follows the fragmentation that characterizes cmvPCD.
###end p 39
###begin title 40
###xml 54 57 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
HtrA2/Omi overexpression early after infection blocks CMV replication
###end title 40
###begin p 41
###xml 147 151 147 151 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000063-Gray1">[34]</xref>
###xml 303 312 303 312 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000063-g007">Fig. 7A&#8211;H</xref>
###xml 314 321 314 321 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="ppat.1000063.s008">Fig. S8</xref>
###xml 411 418 411 418 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000063-g007">Fig. 7H</xref>
###xml 435 442 435 442 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="ppat.1000063.s008">Fig. S8</xref>
###xml 512 516 512 516 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000063-Suzuki1">[37]</xref>
###xml 622 631 622 631 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000063-g007">Fig. 7A&#8211;F</xref>
###xml 745 752 745 752 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000063-g007">Fig. 7G</xref>
###xml 920 927 916 923 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000063-g007">Fig. 7I</xref>
###xml 966 970 962 966 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000063-AuCoin1">[71]</xref>
###xml 1079 1082 1075 1078 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000063-McCormick2">[5]</xref>
###xml 1221 1228 1217 1224 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000063-g007">Fig. 7I</xref>
To directly address the impact of HtrA2/Omi overexpression on the cell fate, full-length HtrA2/Omi as well as a catalytic site mutant (HtrA2S306A) [34] were transiently expressed in uninfected and virus-infected cells. Initially, expression levels and impact on uninfected cell viability were assessed (Fig. 7A-H, Fig. S8). HtrA2/Omi (or mutant HtrA2/Omi) overexpression did not induce death in uninfected HFs (Fig. 7H) or HeLa cells (Fig. S8), consistent with published characterization of full-length protease [37]. Immunofluorescence patterns revealed the expected mitochondrial localization at 48 h post transfection (Fig. 7A-F), and immunoblot analyses using HeLa cells indicated equivalent expression levels of the wt and mutant protease (Fig. 7G). To determine the impact of HtrA2/Omi overexpression on infected cells, Towne-BAC or DeltaUL37x1 were cotransfected with HtrA2/Omi or HtrA2S306A expression plasmids (Fig. 7I) and assessed for spread to form foci [71]. By 10 days posttransfection, wt and mutant BACmids had produced comparable numbers of plaques, as expected [5]. Cotransfection of HtrA2/Omi expression plasmid reduced the plaquing efficiency >10-fold compared to vector control or HtrA2S306A mutant (Fig. 7I). These data show that overexpression of catalytically active HtrA2/Omi prevents plaque formation independent of vMIA expression.
###end p 41
###begin title 42
###xml 61 64 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
Transient overexpression of HtrA2/Omi induces early death in CMV-infected but not uninfected cells.
###end title 42
###begin p 43
(A-F) Immunofluorescent images of HtrA2/Omi (A-C) and GFP fluorescence (D-F) following cotransfection of HF with GFP expression plasmid together with empty vector, HtrA2/Omi, or HtrA2S306A expression plasmids. Original magnification x400. (G) Immunoblot depicting 49 kDa, immature and 36 kDA, mature forms of HtrA2/Omi and HtrA2S306A as well as beta-actin control in transfected HeLa cell lysates. (H) Percentage of live HFs at 120 h post cotransfection of GFP expression plasmid with vector, HtrA2/Omi, or HtrA2S306A expression plasmids. (I) Number of viral plaques 10 days following cotransfection of DeltaUL37x1 or Towne-BAC DNA (500 ng) with 800 ng vector, HtrA2/Omi, or HtrA2S306A expression plasmids. (J) Number of live (intact) cells in cultures at 48 or 72 h following transfection with Towne-BAC DNA (300 ng) alone or with 333 ng of HtrA2 or HtrA2S306A expression plasmids. (K) Number of live (intact) cells (+/-range) at 48 or 72 h post transfection with Towne-BAC DNA (500 ng) and 300 ng of vector or HtrA2/Omi expression plasmid with or without addition of 10 microM UCF-101 from 6 h.
###end p 43
###begin p 44
###xml 173 180 173 180 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="ppat.1000063.s009">Fig. S9</xref>
###xml 389 398 389 398 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000063-g007">Fig. 7J&#8211;K</xref>
###xml 466 473 466 473 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000063-g007">Fig. 7J</xref>
###xml 513 520 513 520 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="ppat.1000063.s009">Fig. S9</xref>
###xml 644 651 644 651 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000063-g007">Fig. 7J</xref>
###xml 753 760 753 760 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000063-g007">Fig. 7K</xref>
###xml 790 797 790 797 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000063-g007">Fig. 7J</xref>
###xml 811 818 811 818 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000063-g007">Fig. 7I</xref>
###xml 1173 1180 1173 1180 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000063-g007">Fig. 7H</xref>
###xml 1255 1258 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
To determine whether the reduction in plaguing efficiency following overexpression of HtrA2/Omi was due to cell death induction, the fate of individual cells was monitored (Fig. S9). When Towne-BAC was cotransfected with HtrA2/Omi or HtrA2S306A, individual GFP+ cells were observed at 48 h, although even at this time the levels could be lower in cells receiving the protease active form (Fig. 7J-K). HtrA2/Omi/GFP+ cells began to fragment by 72 h posttransfection (Fig. 7J) and were lost from cultures by 168 h (Fig. S9). HtrA2/Omi overexpression-induced death required the active protease, based on the failure of HtrA2S306A to induce death (Fig. 7J) as well as on the ability of the inhibitor UCF-101 to block HtrA2/Omi overexpression-induced death (Fig. 7K). The numbers of GFP+ cells (Fig. 7J) or plaques (Fig. 7I) that formed following cotransfection of Towne-BAC with HtrA2S306A could not be distinguished from transfection of Towne-BAC with vector. These data show that overexpression of catalytically active HtrA2/Omi induces infected cell death that is independent of vMIA expression. The sensitivity of virus-infected cells and lack of impact on uninfected HFs (Fig. 7H) supports the specific role of HtrA2/Omi in a novel cell death pathway in CMV-infected cells.
###end p 44
###begin p 45
###xml 306 313 306 313 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000063-g008">Fig. 8A</xref>
###xml 501 508 501 508 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000063-g008">Fig. 8A</xref>
###xml 648 652 648 652 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000063-Hayajneh1">[18]</xref>
###xml 657 660 657 660 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">mut</italic>
###xml 662 671 662 671 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000063-g008">Fig. 8B&#8211;C</xref>
###xml 700 703 700 703 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000063-McCormick2">[5]</xref>
###xml 803 806 803 806 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">mut</italic>
###xml 848 855 848 855 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000063-g008">Fig. 8B</xref>
###xml 1049 1057 1045 1053 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="ppat.1000063.s010">Fig. S10</xref>
###xml 1062 1065 1058 1061 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000063-McCormick2">[5]</xref>
###xml 1338 1341 1334 1337 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">mut</italic>
###xml 1387 1394 1383 1390 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000063-g008">Fig. 8C</xref>
###xml 1497 1504 1493 1500 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000063-g008">Fig. 8B</xref>
###xml 1683 1690 1675 1682 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000063-g008">Fig. 8D</xref>
###xml 1692 1700 1684 1692 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="ppat.1000063.s010">Fig. S10</xref>
###xml 2012 2015 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
A role of vMIA in HtrA2-induced death was investigated using the cotransfection assay carried out using lower doses of expression plasmids as well as using vMIA-expressing cells. Cotransfection of HtrA2/Omi expression plasmid at a 25 or 30-fold lower level revealed a differential impact on these viruses (Fig. 8A), where Towne-BAC exhibited a greater resistance to HtrA2/Omi-induced death. These conditions were also employed to demonstrate that vMIA overexpression overcame HtrA2/Omi-induced death (Fig. 8A). To address the role of vMIA further, HFs as well as HFs stably transduced with retroviruses expressing Myc-tagged vMIA or mutant protein [18] vMIAmut (Fig. 8B-C) were infected. As expected [5], vMIA-HFs suppressed the premature cmvPCD when assessed at 96 and 120 h postinfection, whereas vMIAmut-HF or nontransduced control HFs did not (Fig. 8B). These data suggest the intact antiapoptotic domain of vMIA is required to control premature cmvPCD. The experimental plating efficiency of DeltaUL37x1 virus was the same on either cell line (Fig. S10 and [5]). These results were consistent with a role for vMIA in controlling kinetics of cmvPCD and suggest that similar functional domains of vMIA are required in suppression of apoptosis or HtrA2-dependent cmvPCD. Immunoblot analyses were used to compare transduced vMIA (or vMIAmut) levels relative to native viral expression (Fig. 8C). The lower levels of transduced gene expression likely contribute to the death suppression observed (Fig. 8B). Rescue viruses derived from DeltaUL37x1 confirmed that an intact UL37x1 locus is sufficient to completely control premature death, mitochondrial organization, and viral yield (Fig. 8D, Fig. S10). Overall, these data confirm the critical role of vMIA as a determinant of cmvPCD when induced by overexpression of HtrA2/Omi transfection or during the late phase of infection. Thus, DeltaUL37x1 infection sensitizes to the prodeath impact of HtrA2/Omi, and vMIA controls HtrA2/Omi prodeath pathways during wt CMV infection.
###end p 45
###begin title 46
vMIA suppression of HtrA2/Omi-dependent cmvPCD.
###end title 46
###begin p 47
###xml 508 511 498 501 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">mut</italic>
###xml 658 661 648 651 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">mut</italic>
(A) Average number of live cells (+/-range) in cultures at 72 h post transfection of Towne-BAC DNA (500 ng) with 12 ng of HtrA2/Omi expression plasmid or control vector or post transfection of DeltaUL37x1 DNA (500 ng) with 12 ng of HtrA2/Omi expression plasmid in the absence or presence of 15 ng vMIA-encoding plasmid or 12 ng of control vector in the absence or presence of 15 ng vMIA-encoding plasmid. (B) Percentage of dead cells at 96 and 120 h postinfection (MOI of 0.0001) with DeltaUL37x1 in HF, vMIAmut-HF, or vMIA-HF cultures. 400 cells/foci were evaluated for each condition. (C) Immunoblot detection of native vMIA (vMIA-nat.), vMIA-myc, and vMIAmut-myc in cell lysates collected at various h postinfection (MOI of 3) with DeltaUL37x1 or Towne-BAC. Top, alpha-myc antibody; bottom, alpha-vMIA antibody. (D) Percentage of dead cells at 72, 96, 120, and 148 h postinfection (MOI of 0.0001) with DeltaUL37x1, Towne-BAC, DeltaUL37x1R1, or DeltaUL37x1R2. 100 cells/foci were evaluated for each condition.
###end p 47
###begin title 48
vMIA antiapoptotic function remains intact and independent of HtrA2/Omi during infection
###end title 48
###begin p 49
###xml 232 238 232 238 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000063-g009">Fig. 9</xref>
###xml 240 243 240 243 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000063-Goldmacher1">[2]</xref>
###xml 244 248 244 248 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000063-Smith1">[19]</xref>
###xml 362 371 362 371 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000063-g009">Fig. 9A&#8211;I</xref>
###xml 602 611 602 611 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000063-g009">Fig. 9J&#8211;L</xref>
###xml 727 730 727 730 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000063-McCormick2">[5]</xref>
###xml 731 734 731 734 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000063-Reboredo1">[6]</xref>
In order to determine whether the antiapoptotic activity of vMIA is preserved in cells where HtrA2/Omi is overexpressed, we performed experiments with HtrA2/Omi expression constructs in HeLa cells exposed to Fas-mediated apoptosis (Fig. 9) [2],[19]. Immunofluorescence analyses showed expected levels and localization of HtrA2/Omi and vMIA in transfected cells (Fig. 9A-I). These analyses indicated that vMIA and HtrA2/Omi (or HtrA2S306A) colocalize with mitochondria under all conditions. Introduction of HtrA2/Omi or mutant expression constructs did not influence the antiapoptotic activity of vMIA (Fig. 9J-L), consistent with previous work showing vMIA-dependent antiapoptotic function is active at late times of infection [5],[6]. Together, these data suggest that HtrA2/Omi does not interfere with vMIA-mediated control of apoptosis.
###end p 49
###begin title 50
HtrA2/Omi overexpression does not impede vMIA antiapoptotic activity.
###end title 50
###begin p 51
(A-I) Immunofluorescent images of vMIA (A-C) or HtrA2/Omi (D-F) as well as Hoechst staining (G-I) in HeLa cells following transfection with vMIA together with vector, HtrA2/Omi, or HtrA2S306A expression plasmids. Original magnification x400. (J-L) GFP+ cell number as a percentage of control wells (vector) of HeLa cells cotransfected with vMIA (1 microg) or GFP expression plasmids and 1 microg (J), 2 microg (K), or 3 microg (L) quantities of vector, HtrA2/Omi, or HtrA2S306A DNA. GFP+ cell numbers in vMIA plus vector wells were assigned values of 100%.
###end p 51
###begin title 52
Increased serine protease accumulation in cells undergoing premature cmvPCD
###end title 52
###begin p 53
###xml 215 219 215 219 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000063-Grabarek1">[72]</xref>
###xml 277 284 273 280 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000063-g010">Fig. 10</xref>
###xml 389 399 385 395 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000063-g010">Fig. 10E&#8211;F</xref>
###xml 581 589 573 581 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000063-g010">Fig. 10A</xref>
###xml 735 745 727 737 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000063-g010">Fig. 10A&#8211;B</xref>
###xml 849 857 837 845 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000063-g010">Fig. 10C</xref>
###xml 897 905 885 893 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000063-g010">Fig. 10D</xref>
###xml 1075 1082 1063 1070 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000063-g006">Fig. 6C</xref>
###xml 1322 1330 1310 1318 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="ppat.1000063.s011">Fig. S11</xref>
###xml 1537 1540 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
To directly visualize levels of serine proteases in infected cells, the fluorescent reagent sulforhodamine 101-leucine chloromethyl ketone (SLCK) was used to reveal the distribution and activity of serine proteases [72] in DeltaUL37x1 or Towne-BAC infected live cell cultures (Fig. 10). By day 5, foci with brightly stained GFP+ debris was observed in cultures infected with either virus (Fig. 10E-F), although fragmentation was rare in wt virus-infected cultures at this time. The SLCK staining pattern was distinct in DeltaUL37x1-infected cells and included bright SLCK+ debris (Fig. 10A) that was distinguishable from Towne-BAC infected cells by differences in the amount of staining as well as the size and distribution of debris (Fig. 10A-B). By 8 days after infection, most DeltaUL37x1-infected cells in each plaque were brightly fluorescent (Fig. 10C) whereas cells infected with wt virus (Fig. 10D) showed only SLCK+ debris. SLCK staining patterns did not appear to be mitochondrial at any time in either virus infection. These patterns were distinct from HtrA2/Omi (Fig. 6C), suggesting that SLCK labeling detected serine proteases in addition to HtrA2/Omi. Addition of 0.1 or 1 mM TLCK reduced but did not eliminate SLCK binding to mutant virus-infected cells, consistent with the induction of serine proteases (Fig. S11). Overall, >50% of GFP+ cells in DeltaUL37x1 plaques also labeled with SLCK. SLCK staining was reduced to </=30% by addition of 100 microM TLCK. Thus, SLCK revealed a higher level of protease activation in CMV infected cells that were susceptible to premature cmvPCD. This data suggests that vMIA may control a broader serine protease-dependent death pathway by counteracting mitochondrial HtrA2/Omi during viral infection.
###end p 53
###begin title 54
SLCK localization within infected cells.
###end title 54
###begin p 55
Images of fluorescent serine protease substrate SLCK localization (A-D) and GFP fluorescence (E-H) in DeltaUL37x1 (A, C, E, G) or Towne-BAC (B, D, F, H) foci undergoing fragmentation at 120 h (A-B, E-F) and 192 h (C-D, G-H) postinfection (MOI of 0.001). Arrows indicate SLCK-bound debris. Original magnification x400 (A-H).
###end p 55
###begin title 56
Discussion
###end title 56
###begin p 57
###xml 169 172 169 172 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000063-Mocarski1">[1]</xref>
###xml 397 401 397 401 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000063-Sanchez2">[73]</xref>
###xml 402 406 402 406 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000063-Hertel2">[76]</xref>
###xml 871 872 871 872 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">c</italic>
###xml 953 956 953 956 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000063-Goldmacher1">[2]</xref>
###xml 957 960 957 960 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000063-McCormick1">[4]</xref>
###xml 1808 1809 1808 1809 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">c</italic>
###xml 0 3 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
###xml 300 303 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
###xml 519 522 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
CMV replicates in the nucleus, matures in the cytoplasm and is released into the surrounding medium or adjacent cells over the course of a 7 to 10 day replication cycle [1]. Host cells are dramatically reprogrammed for production of progeny virus until death occurs via a process that begins late in CMV infection, associated with late gene expression that drives CPE and cell cycle dysregulation [73]-[76]. In an effort to define viral and cellular contributions to morphological and biochemical events that terminate CMV infection, we have discovered the key role of mitochondrial HtrA2/Omi and a novel cell death pathway. This cellular serine protease appears to be responsible for induction of cmvPCD following a pathway that is held in balance by the viral cell death suppressor, vMIA. vMIA resides in the mitochondrion where it is a potent suppressor of cytochrome c release, thereby preventing activation of executioner caspases during apoptosis [2]-[4]. In addition to suppression of apoptosis, vMIA carries out a distinct and nonoverlapping role suppressing death induced by HtrA2/Omi during the late phase of viral infection. This cmvPCD pathway is triggered only in the context of infection. Late phase infected cell events promote cell fragmentation together with collapse, shrinkage, and loss of nuclei in a pathway that is dependent on HtrA2/Omi protease activity and associated with the activation of cytoplasmic serine proteases that may act as executioners. HtrA2/Omi levels rise before induction of death, consistent with a central role of this protease in initiation of cmvPCD. Suppression of this death pathway, like suppression of apoptosis, is associated with global disruption of mitochondrial networks by vMIA. Unlike apoptosis, however, cmvPCD apparently does not require cytochrome c release from mitochondria to trigger downstream events. Further, HtrA2/Omi remains mitochondrial late during infection suggesting death may be initiated by the activity of the intramitochondrial protease, which raises an interesting question as to how transduction of the death signal occurs. Our data reveal a pathway that is triggered by high intramitochondrial HtrA2/Omi protease and controlled by vMIA.
###end p 57
###begin p 58
###xml 569 572 569 572 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000063-McCormick2">[5]</xref>
###xml 934 938 934 938 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000063-Krysko1">[77]</xref>
Although vMIA-mutant virus undergoes premature cmvPCD, the fragmentation process is similar to cmvPCD in wt virus-infected cells. The difference appears to be in timing of cell death. vMIA delays death for several days beyond the initiating trigger which is coincident with the late phase of replication. Although induction of HtrA2/Omi is independent of vMIA, the impact of induction appears to be the target of vMIA function at the mitochondria where both reside. Suppression of cmvPCD benefits the virus by extending the period of virus production by infected cells [5], although cultured fibroblasts show only slight reduction in yield and cell-to-cell transmission in the absence of vMIA. A prolonged period of virus production increases the amount of virus released cell-free and potentially benefits transmission in natural settings. A delay in fragmentation would also delay phagocytosis and clearance of virus-infected cells [77]. HtrA2/Omi-dependent death may be viewed as an intrinsic host antiviral process analogous to apoptosis. vMIA control of HtrA2/Omi-mediated death is analogous to control of apoptosis, as both appear to be independent cell-intrinsic mechanisms of pathogen control. Importantly, vMIA appears to provide concurrent protection from both pathways.
###end p 58
###begin p 59
###xml 71 75 71 75 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000063-McCormick4">[22]</xref>
###xml 746 748 742 744 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">++</sup>
###xml 856 860 852 856 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000063-Frazier1">[78]</xref>
vMIA disruption of reticular networks and organization of mitochondria [22] is independent of HtrA2/Omi accumulation within mitochondria, but does correlate with cell death suppression activity. Thus, DeltaUL37x1-mutant virus-infection preserves mitochondrial networks throughout infection, during HtrA2/Omi accumulation and initiation of premature cmvPCD. In contrast, wt virus infected cells support the same accumulation of HtrA2/Omi and a vMIA-driven disruption of mitochondrial networks but survive. The correlation between this vMIA-dependent disruption and cell death protection suggests that punctate mitochondria may be more resistant to the stress induced by late phase events. Reticular mitochondria are known to rapidly disseminate Ca++ or ATP signals; whereas, punctate mitochondria have slower responses to changes in intracellular mediators [78]. Additional experiments will be needed to understand the mechanism underlying resistance of punctate mitochondria to death, whether mediated via caspases or HtrA2/Omi.
###end p 59
###begin p 60
###xml 166 169 166 169 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000063-Reboredo1">[6]</xref>
###xml 228 232 228 232 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000063-McCormick4">[22]</xref>
###xml 385 389 385 389 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000063-Mavinakere1">[79]</xref>
###xml 390 394 390 394 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000063-Mavinakere2">[80]</xref>
###xml 423 426 423 426 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">var</italic>
###xml 563 566 563 566 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">var</italic>
Emerging evidence suggests vMIA, viral strain differences, and cellular factors contribute to the control of mitochondria and death. Thus, AD-BAC kills cells earlier [6] and disrupts mitochondrial networks by 24 h postinfection [22] whereas Towne-BAC disruption occurs later, by 48 h postinfection and cells die later. vMIA associates with the outer mitochondrial membrane within 24 h [79],[80]. AD-BAC (or its parent AD169varATCC) depends upon vMIA to suppress caspase-dependent apoptosis that develops by 48 to 72 h postinfection. Towne-BAC (or its parent TownevarATCC) depends on vMIA to suppress caspase-independent, HtrA2-dependent cell death that develops by 72 to 96 h postinfection. It remains to be seen whether vMIA suppresses both pathways in cells infected with strains like AD-BAC. Accumulation of HtrA2/Omi occurs in other viral strains (McCormick, unpublished), underscoring the overall importance of the process described here. There are many potential factors contributing to qualitative or quantitative differences in the way characterized viral strains initiate and control death, with apoptosis apparently predominating in some settings and HtrA2-mediated death predominating in others. We focused here on dissecting the novel death pathway in Towne-BAC-infected cells, to characterize a novel HtrA2/Omi pathway that is independent of apoptosis.
###end p 60
###begin p 61
###xml 187 191 187 191 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000063-Sanchez2">[73]</xref>
###xml 192 196 192 196 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000063-Hertel2">[76]</xref>
###xml 227 231 227 231 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000063-Rosenke1">[81]</xref>
###xml 253 257 253 257 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000063-Gaspar1">[82]</xref>
###xml 258 262 258 262 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000063-Luo1">[83]</xref>
###xml 293 297 293 297 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000063-Isler1">[84]</xref>
###xml 482 486 482 486 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000063-Poncet2">[85]</xref>
###xml 732 736 732 736 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000063-Reeves1">[86]</xref>
###xml 737 741 737 741 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000063-Tang1">[87]</xref>
###xml 789 793 789 793 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000063-Hertel1">[75]</xref>
###xml 841 845 841 845 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000063-Furukawa1">[88]</xref>
cmvPCD may be influenced by or even associated with a number of additional modulatory effects of this virus that impact late times of infection, including dysregulation of the cell cycle [73]-[76], disruption of p53 activation [81], DNA damage response [82],[83] and unfolded protein response [84] that all remain incompletely understood. vMIA may reduce ATP levels during infection as it does in established cell lines. Although suggested to control late CPE in AD-BAC derivatives [85] vMIA has no impact on development of CPE in Towne-BAC derivatives. Any vMIA-specific reduction in ATP levels is likely highly coordinated with other viral processes contributing to late CPE. CMVs encode multiple factors that target mitochondria [86],[87], regulate expression of mitochondrial proteins [75] and even stimulate mitochondrial DNA synthesis [88] suggesting viral control of mitochondria functions is complex. The vMIA-specific impact on ATP levels as related to HtrA2/Omi remains unknown but may certainly be a feature of control. As an event that occurs very late in replication, cmvPCD is crucial to sustaining viral infection in individual cells. Our observations that either mutation of vMIA or premature overexpression of HtrA2/Omi levels dramatically alters the timing of death indicate that these two may balance each another in controlling cmvPCD.
###end p 61
###begin p 62
###xml 115 119 115 119 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000063-Martins1">[35]</xref>
###xml 120 124 120 124 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000063-Suzuki1">[37]</xref>
###xml 125 129 125 129 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000063-Hegde1">[40]</xref>
###xml 130 134 130 134 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000063-vanLoo2">[89]</xref>
###xml 135 139 135 139 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000063-Verhagen1">[90]</xref>
###xml 249 253 249 253 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000063-Vaux1">[39]</xref>
###xml 254 258 254 258 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000063-Martins2">[91]</xref>
###xml 259 263 259 263 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000063-Jones1">[92]</xref>
###xml 331 335 331 335 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000063-Gray1">[34]</xref>
###xml 383 387 383 387 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000063-Lipinska1">[41]</xref>
###xml 388 392 388 392 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000063-Spiess1">[43]</xref>
###xml 622 626 622 626 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000063-Martins1">[35]</xref>
###xml 627 631 627 631 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000063-Suzuki1">[37]</xref>
###xml 632 636 632 636 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000063-Hegde1">[40]</xref>
###xml 637 641 637 641 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000063-Verhagen1">[90]</xref>
###xml 642 646 642 646 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000063-Blink1">[93]</xref>
###xml 721 724 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
###xml 823 826 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
###xml 838 841 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
Previously, pharmacological inhibitor and overexpression studies have implicated HtrA2/Omi as a regulator of death [35],[37],[40],[89],[90]. Genetic studies have suggested this protease functions primarily to ensure normal mitochondrial homeostasis [39],[91],[92], perhaps controlling protein quality and cellular stress responses [34] similar to the related bacterial protease HtrA [41]-[43]. The role of HtrA2/Omi in caspase-independent cell death has not previously been studied in detail, although the truncated, active form of HtrA2 drives death when released from mitochondria or expressed directly in the cytoplasm [35],[37],[40],[90],[93]. We have shown that the active form drives death specifically and only in CMV-infected cells, which we correlate with the fact that the enzyme remains mitochondrial throughout CMV infection. CMV infection is a unique setting that has unveiled a direct role for HtrA2/Omi in a caspase-independent cell death pathway analogous to apoptosis.
###end p 62
###begin p 63
###xml 898 902 898 902 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000063-Zou1">[94]</xref>
###xml 903 907 903 907 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000063-White1">[96]</xref>
###xml 1094 1098 1094 1098 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000063-Krysko1">[77]</xref>
###xml 1237 1241 1237 1241 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000063-Mocarski2">[97]</xref>
###xml 1575 1578 1575 1578 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000063-McCormick2">[5]</xref>
###xml 1579 1583 1579 1583 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000063-McCormick3">[17]</xref>
###xml 141 144 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
###xml 362 367 <span type="species:ncbi:9606">human</span>
###xml 404 407 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
###xml 1100 1103 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
vMIA controls the programmed death of infected cells after a week or more of replication, following a period of persistent virus production. CMV infects many cell types in addition to HFs, and given that the timing of replication varies with cell type, vMIA control of HtrA2/Omi-dependent death may be critical in other cell types or in natural infection of the human host. Given the many functions that CMV has evolved to manage the virus:host standoff, we speculate that viral control of cmvPCD represents a benefit to the virus, potentially allowing infected cells to avoid sending alarm signals. Other examples of viral proteins acting together to control the type of cell death that follows replication can be identified. Thus, the adenovirus death protein, ADP, functions in the presence of E1B-19k, the viral Bcl-2 protein, and both contribute to the type of death that terminates infection [94]-[96]. Caspase-dependent apoptosis is itself a cell-intrinsic pathogen clearance process, minimizing inflammation and pathology while alarming the immune system to initiate cellular responses [77]. CMV-encoded cell death suppressors provide a means of evading cell death directed by host cell intrinsic, innate, and adaptive responses [97]. The benefit of controlling the mechanism and timing of cell death includes persistence, as well as the interface of virus-infected cells with the host immune system. In the host, cmvPCD may provide for greater success in attaining a foothold without evoking clearance. The presence of vMIA-like functions in other cytomegaloviruses [5],[17] as well as the broad distribution of mitochondrial cell death suppressors in other viruses suggests this novel serine protease pathway may occur in other biological settings.
###end p 63
###begin title 64
Materials and Methods
###end title 64
###begin title 65
Accession numbers
###end title 65
###begin p 66
###xml 185 188 185 188 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000063-Goldmacher1">[2]</xref>
###xml 254 257 250 253 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">var</italic>
###xml 349 352 345 348 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000063-Dunn1">[8]</xref>
The HtrA2 protease has MEROPS accession number S01.278 and the I.M.A.G.E. consortium clone obtained for these studies was identical in sequence to NCBI accession ID BC0000096. The vMIA [2] used to complement and repair DeltaUL37x1 was obtained from AD169varATCC genomic DNA; NCBI accession ID X17403. The sequence of Towne-BAC was deposited to NCBI [8]; accession ID AY315197.
###end p 66
###begin title 67
Cells and viruses
###end title 67
###begin p 68
###xml 39 42 39 42 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">mut</italic>
###xml 96 99 96 99 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000063-McCormick2">[5]</xref>
###xml 166 169 162 165 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000063-Dunn1">[8]</xref>
###xml 203 210 199 206 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E. coli</italic>
###xml 267 270 263 266 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">var</italic>
###xml 314 318 310 314 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000063-McCormick4">[22]</xref>
###xml 0 5 <span type="species:ncbi:9606">Human</span>
###xml 203 210 <span type="species:ncbi:562">E. coli</span>
Human fibroblasts (HFs), vMIA-HFs, vMIAmut-HFs, and HeLas were cultured as previously described [5]. Viruses derived from the BACmid clones Towne-BAC and DeltaUL37x1 [8] were maintained as DNA clones in E. coli or on complementing vMIA-HFs prior to experiments. AD169varATCC was maintained as previously described [22].
###end p 68
###begin title 69
Generation of DeltaUL37x1 rescue virus RC2707
###end title 69
###begin p 70
###xml 100 103 96 99 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">var</italic>
###xml 152 155 148 151 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000063-McCormick2">[5]</xref>
###xml 290 293 282 285 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000063-McCormick2">[5]</xref>
###xml 562 565 542 545 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">var</italic>
###xml 639 642 619 622 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000063-Dunn1">[8]</xref>
###xml 643 647 623 627 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000063-Chee1">[98]</xref>
The kanamycin selection cassette in DeltaUL37x1 was replaced with UL37x1 sequence derived from AD169varATCC to generate RC2707. Transfection of pON2707 [5] into HFs was followed by infection with DeltaUL37x1 virus. Plaques that included cell death at a frequency similar to Towne-BAC virus [5] were isolated for further analysis. Sequencing of viral DNA from Towne-BAC and two independently derived isolates (DeltaUL37x1R1, DeltaUL37x1R2) confirmed replacement of the selection marker in DeltaUL37x1 with UL37x1 nucleotide sequence identical to pON2707 and AD169varATCC while the control, Towne-BAC, was identical to the expected sequence [8],[98]. Expression of vMIA was confirmed by immunoblot analysis.
###end p 70
###begin title 71
Plasmids
###end title 71
###begin p 72
###xml 582 626 582 626 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-CTATTGATTTTGGAAACGCCGGCGGTCCCCTGGTTAAC-3&#8242;</named-content>
###xml 796 799 796 799 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000063-Goldmacher1">[2]</xref>
###xml 800 803 800 803 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000063-McCormick2">[5]</xref>
###xml 804 808 804 808 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000063-Hayajneh1">[18]</xref>
The HtrA2/Omi expression plasmid, pON601, was derived by restriction of the I.M.A.G.E. cDNA (HtraA2 clone #5344667, ATCC, Manassas, VA) with BsrGI, followed by removal of the single-stranded overhangs with Klenow DNA polymerase, and restriction with XhoI. The HtrA2/Omi encoding fragment was ligated to EcoRV and XhoI restricted pcDNA3.1+ (Invitrogen, San Diego, CA). The HtrA2S306A expression plasmid, pON602, was generated by PCR-site directed mutagenesis of the HtrA2 ORF to introduce the S306A mutation and a novel NaeI restriction enzyme site and utilized the mutagenic primer 5'-CTATTGATTTTGGAAACGCCGGCGGTCCCCTGGTTAAC-3'. Both clones were sequenced to confirm expected results. The vMIA and GFP expression clones and retroviral constructs used in these experiments were reported previously [2],[5],[18].
###end p 72
###begin title 73
Immunoblotting, immunofluorescence, and MitoTracker Red staining assays
###end title 73
###begin p 74
###xml 58 61 58 61 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">myc</italic>
###xml 187 188 187 188 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">c</italic>
###xml 451 454 448 451 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p72</sub>
###xml 462 465 459 462 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p86</sub>
###xml 627 630 624 627 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000063-Goldmacher1">[2]</xref>
###xml 990 994 987 991 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000063-McCormick4">[22]</xref>
###xml 1113 1117 1110 1114 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000063-McCormick4">[22]</xref>
###xml 25 30 <span type="species:ncbi:10090">mouse</span>
###xml 584 590 <span type="species:ncbi:9986">rabbit</span>
###xml 657 662 <span type="species:ncbi:9796">horse</span>
###xml 668 673 <span type="species:ncbi:10090">mouse</span>
###xml 681 685 <span type="species:ncbi:9925">goat</span>
###xml 691 697 <span type="species:ncbi:9986">rabbit</span>
###xml 724 729 <span type="species:ncbi:9796">horse</span>
###xml 735 740 <span type="species:ncbi:10090">mouse</span>
###xml 813 817 <span type="species:ncbi:9925">goat</span>
###xml 823 828 <span type="species:ncbi:10090">mouse</span>
Immunodetection employed mouse monoclonal antibodies to c-myc epitope (9E10; Santa Cruz Biotechnology, Santa Cruz, CA), HtrA2/Omi (MAB1458; R&D Systems, Inc, Minneapolis, MN), cytochrome c (Clone 7H8.2C12, BD Pharmingen, San Jose, CA), beta-actin (AC-74, Sigma, St. Louis, MO), golgin-97 (CDF4; Molecular Probes, Eugene, OR), mitochondrial heat shock protein 70 (mtHSP70) (a gift from Susan Pierce, Northwestern University), viral nuclear antigens IE1p72 and IE2p86 (MAB 810, Chemicon, Temeculah, CA), ICP36 (CH16) and pp28 (CH19) (both from Virusys Corporation, Randallstown, MD) or rabbit polyclonal antiserum to native vMIA [2] and peroxidase-conjugated horse anti-mouse IgG or goat anti-rabbit IgG, Texas Red-conjugated horse anti-mouse IgG (all from Vector, Burlingame, Calif.), or AlexaFluor 350-conjugated goat anti-mouse IgG (Molecular Probes, Eugene, OR). Immunoblot analysis of total protein from infected cells and immunofluorescence assays followed previously described methods [22]. MitoTracker Red CMXRos (Molecular Probes, Eugene, OR) staining of mitochondria followed previously described methods [22].
###end p 74
###begin title 75
Detection of cmvPCD, impact of replication and protease inhibitors on death, viral yield, and BACmid transfections
###end title 75
###begin p 76
###xml 352 356 352 356 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000063-McCormick4">[22]</xref>
###xml 467 470 467 470 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000063-McCormick2">[5]</xref>
To assess morphological changes in infected cells and nuclei, cells grown on coverslips and infected for varying periods of time were fixed with 3.7% formaldehyde, permeabilized with Triton X-100 (EMD Biosciences, Darmstadt, Germany), stained with Hoechst 33258 (AnaSpec, San Jose, CA), and processed for microscopic evaluation as previously described [22]. Some cultures were stained with ethidium homodimer 1 (Molecular Probes, Eugene, OR), as previously described [5] to assess virus-induced cell death.
###end p 76
###begin p 77
###xml 69 72 69 72 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000063-McCormick2">[5]</xref>
Images from live cell cultures were obtained as previously described [5] or utilized Simple PCI software, a Retiga Exi digital camera, and a Leica DM IRB microscope. Imaging of cultures grown on coverslip employed an AxioCam MRc5 camera attached to a Zeiss Axio Imager.A1 and AxioVision Release 4.5 software.
###end p 77
###begin p 78
###xml 655 658 655 658 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p72</sub>
###xml 666 669 666 669 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p86</sub>
###xml 807 810 807 810 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000063-McCormick2">[5]</xref>
###xml 905 908 903 906 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000063-McCormick2">[5]</xref>
###xml 833 836 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
###xml 846 849 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
Replication inhibitors included phosphonoformate (PFA Sigma, St. Louis, Mo) dissolved in water and 2-bromo-5,6-dichlorobenzimidazole (BDCRB from L. B. Townsend, University of Michigan) dissolved in dimethyl sulfoxide (DMSO) (Sigma, St. Louis, MO). Protease inhibitors included TLCK, N-alpha-p-tosyl-L-lysine chloromethyl ketone, (Sigma, St. Louis, MO) in water, and UCF-101 or zVAD.fmk (both from Calbiochem, La Jolla, CA) dissolved in DMSO. Inhibitors were added by replacing culture medium with medium containing inhibitor while control medium included the appropriate solvent (DMSO) or no addition. Morphology and presence of viral nuclear antigens IE1p72 and IE2p86 were assessed as described above and viral yield was determined from total virus recovered on day 7 from supernatant and sonicated cells [5]. DMSO does not impact CMV death or CMV replication levels at the concentrations used (</=0.1%)[5].
###end p 78
###begin p 79
###xml 48 51 48 51 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000063-McCormick2">[5]</xref>
###xml 259 262 259 262 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p72</sub>
###xml 270 273 270 273 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p86</sub>
###xml 327 330 327 330 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000063-McCormick2">[5]</xref>
Transfections of BACmid DNA have been described [5]. GFP-positive (GFP+) cells and GFP-positive foci (>2 GFP+ cell) were evaluated by live cell microscopy 2-10 days post transfection. Viral presence was confirmed by immunodection of viral nuclear antigens IE1p72 and IE2p86 and some experiments utilized a plasmid encoding GFP [5] for detection of transfected cells. Reported results were obtained from multiple DNA preparations.
###end p 79
###begin title 80
Apoptosis and viability assays
###end title 80
###begin p 81
###xml 38 41 38 41 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">var</italic>
###xml 136 139 136 139 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000063-Goldmacher1">[2]</xref>
###xml 140 144 140 144 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000063-Skaletskaya1">[64]</xref>
###xml 284 287 284 287 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p72</sub>
###xml 295 298 295 298 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p86</sub>
###xml 302 305 302 305 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">var</italic>
Conditions for induced apoptosis of ADvarATCC infections and vMIA-dependent survival following transfection of HeLa have been described [2],[64]. Cell numbers were determined following Hoechst stain of surviving cells (HeLas) or following immunodetection of viral nuclear antigens IE1p72 and IE2p86 (ADvarATCC), comparing to untreated controls.
###end p 81
###begin p 82
To assess the impact of HtrA2/Omi on HFs, GFP expression plasmid was cotransfected with control DNA (vector) or HtrA2/Omi or HtrA2S306A expression plasmids. By 48 h cells had recovered and were confluent. Images obtained of GFP fluorescence at 24 h intervals between 48-120 h post transfection were evaluated for numbers of GFP+ cells from 12 microscopic fields per day. Mean % survival (+/-standard deviation) was calculated from numbers of GFP+ cells compared to those at 48 h.
###end p 82
###begin title 83
SLCK labeling
###end title 83
###begin p 84
Sulforhodamine 101-leucine chloromethyl ketone, SLCK, (Immunochemistry Technologies, LLC, Bloomington, MN) was suspended in DMSO (Sigma, St. Louis, MO). For labeling, 2.5 microM SLCK was applied in the presence or absence of TLCK to live cultures for 30 minutes prior to fixation and imaging as described above.
###end p 84
###begin title 85
Supporting Information
###end title 85
###begin p 86
Towne-BAC cmvPCD occurs after viral release. Examples of single infected cells (A, B) or foci (C, D) remaining intact and live (A, C) or exhibiting fragmentation and death (cmvPCD) (B, D) are shown. Original magnification x400. (E) Percentages of single infected cells (patterns A+B) and foci (patterns C+D) for DeltaUL37x1 and Towne-BAC. (F) Percentages of live, nonfragmented single cells or foci at 72, 96, or 120 h postinfection (hpi) with DeltaUL37x1 or Towne-BAC. (G) Percentages of dead single cells or foci at 72, 96, or 120 hpi with DeltaUL37x1 or Towne-BAC. A total of 400 infected cells/foci per virus were evaluated at each time for the experiment depicted in panels E-G following infection at MOI 0.0001. The mean+/-sd is depicted in all figures, except where indicated.
###end p 86
###begin p 87
(1.84 MB TIF)
###end p 87
###begin p 88
Click here for additional data file.
###end p 88
###begin p 89
Nuclear and cytoplasmic inclusions indicate similar late cytopathic effects in Towne-BAC and DeltaUL37x1 infections. Representative fluorescent images of nuclear and cytoplasmic inclusion proteins ppUL44 (A, C) and ppUL28 (E, I) (red), respectively, in DeltaUL37x1 (A-B, E-H) and Towne-BAC (C-D, I-L) infected cells (MOI of 0.001). (GFP = green, Hoechst = blue) Original magnification x1000.
###end p 89
###begin p 90
(6.21 MB TIF)
###end p 90
###begin p 91
Click here for additional data file.
###end p 91
###begin p 92
cmvPCD intermediates do not stain with ethidium homodimer. Representative fluorescent images of GFP (A, E, I, M, Q) (green), ethidium homodimer (B, F, J, N, R, U) (red), Hoechst (C, G, K, O, S, V) (blue), and merged images (D, H, L, P, T, W) in DeltaUL37x1 infected intact (A-D) or fragmenting (E-T) cells stained prior to fixation, and in controls fixed with methanol prior to labeling (U, V, W). Original magnification x1000.
###end p 92
###begin p 93
(2.45 MB TIF)
###end p 93
###begin p 94
Click here for additional data file.
###end p 94
###begin p 95
Towne-BAC death intermediates. Representative fluorescent images of Towne-BAC infected cells (MOI of 0.01) showing cmvPCD (A-D) at 168 h postinfection (hpi). Original magnification x400.
###end p 95
###begin p 96
(1.99 MB TIF)
###end p 96
###begin p 97
Click here for additional data file.
###end p 97
###begin p 98
###xml 31 34 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
HtrA2/Omi expression following CMV infection. Immunoblot analyses of HtrA2/Omi in lysates of mock-infected HF (M) or HF infected (MOI of 3) with Towne-BAC or DeltaUL37x1 for 24, 48, 72, 96, or 120 h. Control cell lysates from HeLa cells transfected with HtrA2/Omi expression plasmid (+) or control plasmid (-). Immunoblot detection of HtrA2, beta-actin and IE1 are shown.
###end p 98
###begin p 99
(0.50 MB TIF)
###end p 99
###begin p 100
Click here for additional data file.
###end p 100
###begin p 101
Mitochondria are reticular in DeltaUL37x1 and punctate in Towne-BAC infections. Representative fluorescent images of mitochondria HSP70 (mtHSP70) (A, E), golgin 97 (I, M), HtrA2/Omi (Q, U), and cytochrome c (Y, c) (blue), and MitoTracker Red stain of mitochondria (B, F, J, N, R, V, Z, d) (red), and GFP fluorescence (C, G, K, O, S, W, a, e) (green) and merged images (D, H, L, P, T, X, b, f) at 72 h postinfection (MOI of 0.001) with DeltaUL37x1 (A-D, I-L, Q-T, Y-b) or Towne-BAC (E-H, M-P, U-X, c-f). Original magnification x1000.
###end p 101
###begin p 102
(3.53 MB DOC)
###end p 102
###begin p 103
Click here for additional data file.
###end p 103
###begin p 104
Reticular cytochrome c pattern maintained until after initiation of cmvPCD. Representative fluorescent images of cytochrome c (A, D, G, J, M), GFP fluorescence (B, E, H, K N) and Hoechst (C, F, I, L, O) at 96 h postinfection (MOI of 0.001) in fragmented DeltaUL37x1 infected cells. Arrow in B indicates fragments of GFP+ cell. Original magnification x1000.
###end p 104
###begin p 105
(4.19 MB TIF)
###end p 105
###begin p 106
Click here for additional data file.
###end p 106
###begin p 107
HtrA2 overexpression in HeLa cells does not induce death. GFP fluorescence following cotransfection of HF with GFP expression plasmid together with empty vector, HtrA2/Omi or HtrA2S306A expression plasmids at 24, 48, and 72 h posttransfection. Original magnification x40.
###end p 107
###begin p 108
(2.56 MB TIF)
###end p 108
###begin p 109
Click here for additional data file.
###end p 109
###begin p 110
HtrA2 reduces plaque formation following a decrease in viability of infected cells evident by 72 h postinfection. Combined numbers of GFP+ cells and foci following cotransfection of Towne-BAC DNA (500 ng) with 800 ng vector or HtrA2/Omi expression plasmid.
###end p 110
###begin p 111
(0.16 MB TIF)
###end p 111
###begin p 112
Click here for additional data file.
###end p 112
###begin p 113
vMIA impact on cmvPCD. (A) Total number of DeltaUL37x1 plaques on day 10 following infection at MOI 0.0001 of HF, vMIAmut-HF, or vMIA-HF (B) Total viral yield following infection of HF by DeltaUL37x1, Towne-BAC, DeltaUL37x1R1, or DeltaUL37x1R2 for 10 days at MOI 0.0001. (C-H) Mitochondria in DeltaUL37x1R1 and DeltaUL37x1R2 infected cells at 72 h postinfection. MitoTracker Red stain (C-F) (red), GFP fluorescence (D, G), and the merged images. Original magnification x1000.
###end p 113
###begin p 114
(4.66 MB TIF)
###end p 114
###begin p 115
Click here for additional data file.
###end p 115
###begin p 116
Serine proteases labeled with SLCK and impact of TLCK added as inhibitor. Representative images of fluorescent serine protease substrate SLCK localization (A-C) and GFP fluorescence (D-F) in DeltaUL37x1 foci undergoing fragmentation on day 8 postinfection (MOI of 0.001) in the presence of no addition (A, D), 100 microM TLCK (B, E), or 1 mM TLCK (C, F) Original magnification x200.
###end p 116
###begin p 117
(4.49 MB TIF)
###end p 117
###begin p 118
Click here for additional data file.
###end p 118
###begin p 119
We gratefully acknowledge the contribution of William Kaiser, who derived the HtrA2 and HtrA2S306A expression clones and supported this project, as well as Yin Dong, Jaya Rajamani, and Amy Cupples, who all provided tissue culture support for this project.
###end p 119
###begin title 120
References
###end title 120
###begin article-title 121
Cytomegaloviruses.
###end article-title 121
###begin article-title 122
A cytomegalovirus-encoded mitochondria-localized inhibitor of apoptosis structurally unrelated to Bcl-2.
###end article-title 122
###begin article-title 123
Cell death suppression by cytomegaloviruses.
###end article-title 123
###begin article-title 124
Betaherpesvirus modulation of the host response to infection.
###end article-title 124
###begin article-title 125
###xml 48 53 <span type="species:ncbi:9606">human</span>
###xml 58 80 <span type="species:ncbi:10366">murine cytomegalovirus</span>
Mitochondrial cell death suppressors carried by human and murine cytomegalovirus confer resistance to proteasome inhibitor-induced apoptosis.
###end article-title 125
###begin article-title 126
###xml 0 21 <span type="species:ncbi:10359">Human cytomegalovirus</span>
Human cytomegalovirus proteins encoded by UL37 exon 1 protect infected fibroblasts against virus-induced apoptosis and are required for efficient virus replication.
###end article-title 126
###begin article-title 127
###xml 18 39 <span type="species:ncbi:10359">human cytomegalovirus</span>
Functional map of human cytomegalovirus AD169 defined by global mutational analysis.
###end article-title 127
###begin article-title 128
###xml 26 47 <span type="species:ncbi:10359">human cytomegalovirus</span>
Functional profiling of a human cytomegalovirus genome.
###end article-title 128
###begin article-title 129
###xml 0 21 <span type="species:ncbi:10359">Human cytomegalovirus</span>
Human cytomegalovirus UL38 protein blocks apoptosis.
###end article-title 129
###begin article-title 130
Multiple cell death pathways as regulators of tumour initiation and progression.
###end article-title 130
###begin article-title 131
Apoptosis, autophagy, and more.
###end article-title 131
###begin article-title 132
Cell death by necrosis: towards a molecular definition.
###end article-title 132
###begin article-title 133
Do inducers of apoptosis trigger caspase-independent cell death?
###end article-title 133
###begin article-title 134
Viruses and apoptosis.
###end article-title 134
###begin article-title 135
Viral modulators of cell death provide new links to old pathways.
###end article-title 135
###begin article-title 136
Viral Bcl-2 homologs and their role in virus replication and associated diseases.
###end article-title 136
###begin article-title 137
Differential function and expression of the viral inhibitor of caspase 8-induced apoptosis (vICA) and the viral mitochondria-localized inhibitor of apoptosis (vMIA) cell death suppressors conserved in primate and rodent cytomegaloviruses.
###end article-title 137
###begin article-title 138
###xml 57 78 <span type="species:ncbi:10359">human cytomegalovirus</span>
The sequence and antiapoptotic functional domains of the human cytomegalovirus UL37 exon 1 immediate early protein are conserved in multiple primary strains.
###end article-title 138
###begin article-title 139
Contribution of GADD45 family members to cell death suppression by cellular Bcl-xL and cytomegalovirus vMIA.
###end article-title 139
###begin article-title 140
Cytomegalovirus cell death suppressor vMIA blocks Bax- but not Bak-mediated apoptosis by binding and sequestering Bax at mitochondria.
###end article-title 140
###begin article-title 141
An anti-apoptotic viral protein that recruits Bax to mitochondria.
###end article-title 141
###begin article-title 142
###xml 44 65 <span type="species:ncbi:10359">human cytomegalovirus</span>
Disruption of mitochondrial networks by the human cytomegalovirus UL37 gene product viral mitochondrion-localized inhibitor of apoptosis.
###end article-title 142
###begin article-title 143
Bax and Bak coalesce into novel mitochondria-associated clusters during apoptosis.
###end article-title 143
###begin article-title 144
The role of dynamin-related protein 1, a mediator of mitochondrial fission, in apoptosis.
###end article-title 144
###begin article-title 145
Structure-function analysis of the interaction between Bax and the cytomegalovirus-encoded protein vMIA.
###end article-title 145
###begin article-title 146
How do Bax and Bak lead to permeabilization of the outer mitochondrial membrane?
###end article-title 146
###begin article-title 147
A family of stress-inducible GADD45-like proteins mediate activation of the stress-responsive MTK1/MEKK4 MAPKKK.
###end article-title 147
###begin article-title 148
Roles of the mammalian mitochondrial fission and fusion mediators Fis1, Drp1, and Opa1 in apoptosis.
###end article-title 148
###begin article-title 149
Drp-1-dependent division of the mitochondrial network blocks intraorganellar Ca2+ waves and protects against Ca2+-mediated apoptosis.
###end article-title 149
###begin article-title 150
Mitochondrial fusion and fission in the control of apoptosis.
###end article-title 150
###begin article-title 151
Mitochondrial intermembrane proteins in cell death.
###end article-title 151
###begin article-title 152
Toxic proteins released from mitochondria in cell death.
###end article-title 152
###begin article-title 153
Mitochondrial control of cell death.
###end article-title 153
###begin article-title 154
###xml 20 25 <span type="species:ncbi:9606">human</span>
Characterization of human HtrA2, a novel serine protease involved in the mammalian cellular stress response.
###end article-title 154
###begin article-title 155
The serine protease Omi/HtrA2 regulates apoptosis by binding XIAP through a reaper-like motif.
###end article-title 155
###begin article-title 156
Mitochondrial import of Omi: The definitive role of the putative transmembrane region and multiple processing sites in the amino-terminal segment.
###end article-title 156
###begin article-title 157
A serine protease, HtrA2, is released from the mitochondria and interacts with XIAP, inducing cell death.
###end article-title 157
###begin article-title 158
The mitochondrial death squad: hardened killers or innocent bystanders?
###end article-title 158
###begin article-title 159
###xml 13 18 <span type="species:ncbi:9940">sheep</span>
HtrA2/Omi, a sheep in wolf's clothing.
###end article-title 159
###begin article-title 160
Identification of Omi/HtrA2 as a mitochondrial apoptotic serine protease that disrupts inhibitor of apoptosis protein-caspase interaction.
###end article-title 160
###begin article-title 161
###xml 39 55 <span type="species:ncbi:562">Escherichia coli</span>
The HtrA (DegP) protein, essential for Escherichia coli survival at high temperatures, is an endopeptidase.
###end article-title 161
###begin article-title 162
###xml 4 20 <span type="species:ncbi:562">Escherichia coli</span>
The Escherichia coli heat shock protease HtrA participates in defense against oxidative stress.
###end article-title 162
###begin article-title 163
A temperature-dependent switch from chaperone to protease in a widely conserved heat shock protein.
###end article-title 163
###begin article-title 164
###xml 0 21 <span type="species:ncbi:10359">Human cytomegalovirus</span>
Human cytomegalovirus with IE-2 (UL122) deleted fails to express early lytic genes.
###end article-title 164
###begin article-title 165
Inhibition of cytomegalovirus late antigens by phosphonoformate.
###end article-title 165
###begin article-title 166
###xml 14 35 <span type="species:ncbi:10359">human cytomegalovirus</span>
Inhibition of human cytomegalovirus DNA maturation by a benzimidazole ribonucleoside is mediated through the UL89 gene product.
###end article-title 166
###begin article-title 167
Formation of cytomegalovirus DNA replication compartments defined by localization of viral proteins and DNA synthesis.
###end article-title 167
###begin article-title 168
###xml 97 118 <span type="species:ncbi:10359">human cytomegalovirus</span>
Accumulation of virion tegument and envelope proteins in a stable cytoplasmic compartment during human cytomegalovirus replication: characterization of a potential site of virus assembly.
###end article-title 168
###begin article-title 169
Inhibitors of proteases prevent endonucleolysis accompanying apoptotic death of HL-60 leukemic cells and normal thymocytes.
###end article-title 169
###begin article-title 170
Inhibition of drug-induced DNA fragmentation, but not cell death, of glioma cells by non-caspase protease inhibitors.
###end article-title 170
###begin article-title 171
A pre-existing protease is a common effector of thymocyte apoptosis mediated by diverse stimuli.
###end article-title 171
###begin article-title 172
Ionizing radiation-induced, Bax-mediated cell death is dependent on activation of cysteine and serine proteases.
###end article-title 172
###begin article-title 173
Different patterns of apoptosis of HL-60 cells induced by cycloheximide and camptothecin.
###end article-title 173
###begin article-title 174
Photodynamic therapy induces caspase-3 activation in HL-60 cells.
###end article-title 174
###begin article-title 175
Evidence that non-caspase proteases are required for chromatin degradation during apoptosis.
###end article-title 175
###begin article-title 176
Effect of inhibitors of cysteine and serine proteases in anticancer drug-induced apoptosis in gastric cancer cells.
###end article-title 176
###begin article-title 177
Nuclear serine protease activity contributes to bile acid-induced apoptosis in hepatocytes.
###end article-title 177
###begin article-title 178
Involvement of TLCK-sensitive serine protease in colchicine-induced cell death of sympathetic neurons in culture.
###end article-title 178
###begin article-title 179
Internucleosomal DNA cleavage in apoptotic WEHI 231 cells is mediated by a chymotrypsin-like protease.
###end article-title 179
###begin article-title 180
Ethanol-induced apoptosis in hepatoma cells proceeds via intracellular Ca(2+) elevation, activation of TLCK-sensitive proteases, and cytochrome c release.
###end article-title 180
###begin article-title 181
Inhibitors of trypsin-like serine proteases prevent DNA damage-induced neuronal death by acting upstream of the mitochondrial checkpoint and of p53 induction.
###end article-title 181
###begin article-title 182
Dual role of NF-kappaB in apoptosis of THP-1 cells during treatment with etoposide and lipopolysaccharide.
###end article-title 182
###begin article-title 183
###xml 0 21 <span type="species:ncbi:10359">Human cytomegalovirus</span>
###xml 61 77 <span type="species:ncbi:562">Escherichia coli</span>
Human cytomegalovirus maturational proteinase: expression in Escherichia coli, purification, and enzymatic characterization by using peptide substrate mimics of natural cleavage sites.
###end article-title 183
###begin article-title 184
A cytomegalovirus-encoded inhibitor of apoptosis that suppresses caspase-8 activation.
###end article-title 184
###begin article-title 185
Inhibitor of apoptosis proteins are substrates for the mitochondrial serine protease Omi/HtrA2.
###end article-title 185
###begin article-title 186
The serine protease Omi/HtrA2 is released from mitochondria during apoptosis. Omi interacts with caspase-inhibitor XIAP and induces enhanced caspase activity.
###end article-title 186
###begin article-title 187
Autocatalytic processing of HtrA2/Omi is essential for induction of caspase-dependent cell death through antagonizing XIAP.
###end article-title 187
###begin article-title 188
Characterization of a novel and specific inhibitor for the pro-apoptotic protease Omi/HtrA2.
###end article-title 188
###begin article-title 189
The protease inhibitor Ucf-101 induces cellular responses independently of its known target, HtrA2/Omi.
###end article-title 189
###begin article-title 190
###xml 35 56 <span type="species:ncbi:10359">human cytomegalovirus</span>
Three-dimensional structure of the human cytomegalovirus cytoplasmic virion assembly complex includes a reoriented secretory apparatus.
###end article-title 190
###begin article-title 191
Betaherpesvirus-conserved cytomegalovirus tegument protein ppUL32 (pp150) controls cytoplasmic events during virion maturation.
###end article-title 191
###begin article-title 192
In situ activation of caspases and serine proteases during apoptosis detected by affinity labeling their enzyme active centers with fluorochrome-tagged inhibitors.
###end article-title 192
###begin article-title 193
###xml 108 129 <span type="species:ncbi:10359">human cytomegalovirus</span>
Cyclin-dependent kinase activity is required at early times for accurate processing and accumulation of the human cytomegalovirus UL122-123 and UL37 immediate-early transcripts and at later times for virus production.
###end article-title 193
###begin article-title 194
###xml 90 111 <span type="species:ncbi:10359">human cytomegalovirus</span>
Mechanisms governing maintenance of Cdk1/cyclin B1 kinase activity in cells infected with human cytomegalovirus.
###end article-title 194
###begin article-title 195
Global analysis of host cell gene expression late during cytomegalovirus infection reveals extensive dysregulation of cell cycle gene expression and induction of Pseudomitosis independent of US28 function.
###end article-title 195
###begin article-title 196
Viral and Cell Cycle-Regulated Kinases in Cytomegalovirus-Induced Pseudomitosis and Replication.
###end article-title 196
###begin article-title 197
Clearance of apoptotic and necrotic cells and its immunological consequences.
###end article-title 197
###begin article-title 198
Mitochondrial morphology and distribution in mammalian cells.
###end article-title 198
###begin article-title 199
###xml 22 43 <span type="species:ncbi:10359">human cytomegalovirus</span>
Dual targeting of the human cytomegalovirus UL37 exon 1 protein during permissive infection.
###end article-title 199
###begin article-title 200
###xml 14 35 <span type="species:ncbi:10359">human cytomegalovirus</span>
Processing of human cytomegalovirus UL37 mutant glycoproteins in the endoplasmic reticulum lumen prior to mitochondrial importation.
###end article-title 200
###begin article-title 201
###xml 63 84 <span type="species:ncbi:10359">human cytomegalovirus</span>
An intact sequence-specific DNA-binding domain is required for human cytomegalovirus-mediated sequestration of p53 and may promote in vivo binding to the viral genome during infection.
###end article-title 201
###begin article-title 202
###xml 0 21 <span type="species:ncbi:10359">Human cytomegalovirus</span>
Human cytomegalovirus inhibits a DNA damage response by mislocalizing checkpoint proteins.
###end article-title 202
###begin article-title 203
###xml 0 21 <span type="species:ncbi:10359">Human cytomegalovirus</span>
Human cytomegalovirus disrupts both ataxia telangiectasia mutated protein (ATM)- and ATM-Rad3-related kinase-mediated DNA damage responses during lytic infection.
###end article-title 203
###begin article-title 204
###xml 0 21 <span type="species:ncbi:10359">Human cytomegalovirus</span>
Human cytomegalovirus infection activates and regulates the unfolded protein response.
###end article-title 204
###begin article-title 205
Cytopathic effects of the cytomegalovirus-encoded apoptosis inhibitory protein vMIA.
###end article-title 205
###begin article-title 206
Complex I binding by a virally encoded RNA regulates mitochondria-induced cell death.
###end article-title 206
###begin article-title 207
###xml 36 58 <span type="species:ncbi:10366">murine cytomegalovirus</span>
Experimental confirmation of global murine cytomegalovirus open reading frames by transcriptional detection and partial characterization of newly described gene products.
###end article-title 207
###begin article-title 208
###xml 0 21 <span type="species:ncbi:10359">Human cytomegalovirus</span>
Human cytomegalovirus infection of WI-38 cells stimulates mitochondrial DNA synthesis.
###end article-title 208
###begin article-title 209
The role of mitochondrial factors in apoptosis: a Russian roulette with more than one bullet.
###end article-title 209
###begin article-title 210
HtrA2 promotes cell death through its serine protease activity and its ability to antagonize inhibitor of apoptosis proteins.
###end article-title 210
###begin article-title 211
###xml 102 106 <span type="species:ncbi:10090">mice</span>
Neuroprotective role of the Reaper-related serine protease HtrA2/Omi revealed by targeted deletion in mice.
###end article-title 211
###begin article-title 212
###xml 93 97 <span type="species:ncbi:10090">mice</span>
Loss of Omi mitochondrial protease activity causes the neuromuscular disorder of mnd2 mutant mice.
###end article-title 212
###begin article-title 213
###xml 107 112 <span type="species:ncbi:9606">human</span>
Intramitochondrial serine protease activity of Omi/HtrA2 is required for caspase-independent cell death of human neutrophils.
###end article-title 213
###begin article-title 214
Overexpression of adenovirus E3-11.6K protein induces cell killing by both caspase-dependent and caspase-independent mechanisms.
###end article-title 214
###begin article-title 215
The adenovirus death protein (E3-11.6K) is required at very late stages of infection for efficient cell lysis and release of adenovirus from infected cells.
###end article-title 215
###begin article-title 216
The 19-kilodalton adenovirus E1B transforming protein inhibits programmed cell death and prevents cytolysis by tumor necrosis factor alpha.
###end article-title 216
###begin article-title 217
Immunomodulation by cytomegaloviruses: manipulative strategies beyond evasion.
###end article-title 217
###begin article-title 218
###xml 58 79 <span type="species:ncbi:10359">human cytomegalovirus</span>
Analysis of the protein-coding content of the sequence of human cytomegalovirus strain AD169.
###end article-title 218
###begin p 219
The authors have declared that no competing interests exist.
###end p 219
###begin p 220
This work was supported by PHS grant RO1 AI020211, as well as Emory University and Georgia Cancer Coalition funds awarded to E.S.M.
###end p 220

